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CHAPTER I 
INTRODUCTION 

INTRODUCTION 
Of the experimental models of glomerulonephritis those 
induced by antibodies against renal tissue antigens are the 
oldest and best known. Already in 1900, Lindeman demonstrated 
in rabbits that i.v. injection of anti-rabbit kidney serum, 
produced in guinea pigs, induced a nephrotoxic nephritis (1). 
In 1931 and 1932 Masugi et al were able to induce renal 
lesions closely resembling those of human glomerulonephritis 
by injection of heterologous anti-kidney sera into rats and 
rabbits (2,3). From that time this type of experimental renal 
disease, the so-called Masugi nephritis, has been an object 
of study for many investigators. Krakower and Greenspon 
showed in 1951 that injected nephrotoxic antisera reacted 
with the glomerular basement membrane (GBM) and they conclu-
ded, that, therefore, the target antigens had to be situated 
in the GBM itself (4). Since then, nephrotoxic nephritis was 
also called anti-GBM nephritis. Kay was the first to show the 
importance of the host's response against the injected 
nephrotoxic serum (5). He postulated that heterologous 
nephrotoxic serum could become fixed in the kidney without 
causing direct injury. After this fixation an immune response 
of the host against the foreign protein could then result in 
glomerulonephritis. Thus the first phase, or so-called 
heterologous phase, appeared to be followed by a second or 
autologous phase in which host antibodies fix to the hetero-
logous antibodies already deposited in the kidney. 
That Kay found no glomerular damage during the heterologous 
phase must be attributed to the relatively low dose of 
antibody he administered. In later studies it has been shown 
that, when sufficient amounts of antibody are injected, 
severe glomerular damage will develop within a few hours 
after the injection (6). Since our study has focused on the 
heterologous phase, we will mainly confine our introductory 
review to the mediator systems that play a role during this 
phase of the anti-GBM nephritis. 
Although under special circumstances the binding of anti-GBM 
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antibody within the glomerulus may by itself lead to trans­
ient proteinuria, the major damage occurs as a consequence of 
activation of cellular and/or humoral mediator systems. The 
most important mediators of the initial inflammation are the 
complement system and polymorphonuclear granulocytes (PMNs). 
These effector systems may act individually or in concert, 
depending on several factors, such as the characteristics and 
dosage of the injected antibodies used, and the species in 
which the glomerulonephritis is induced (7-17). 
The usual chain of events in anti-GBM nephritis is as fol­
lows. Antibody fixation leads to the activation of the 
complement system. The generation of the chemotactic peptide 
C5a results in neutrophil attraction to the site of immune 
deposits. To a lesser extent, neutrophils also might localize 
in the kidney through immune adherence mechanisms involving 
C3b receptors and activated C3. Neutrophil-mediated injury 
presumably involves proteolytic digestion of GBM by enzymes, 
released locally by invading neutrophils. Recent studies have 
suggested a role for reactive oxygen metabolites (ROMs) in 
neutrophil-mediated tissue injury (18,19). These ROMs include 
superoxide anion (0~2), hydrogen peroxide (H2O2) and hydroxyl 
radicals (·0Η), released during the respiratory burst by 
activated neutrophils. 
The morphologic events that follow injection of anti-GBM 
antibody start with the immediate binding of the heterologous 
antibody to the GBM in a linear pattern as detected by 
immunofluorescence. Deposition of activated complement 
components occurs almost simultaneously. With 15 to 30 
minutes the glomeruli have become infiltrated by PMNs. In 
electron microscopic studies one can see damage of endotheli­
al cells and adherence of infiltrating PMNs to the denuded 
GBM. When there is severe damage, especially after high doses 
of antibody, fibrin thrombi can be found in the glomeruli, 
starting already at 2 hours, and being abundantly present at 
24 hours after the injection of antibody. At later stages 
mononuclear cells, especially monocytes, can be detected in 
the glomeruli. These cells are, however, most prominent 
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during the autologous phase and do not seem to contribute to 
the proteinuria in the heterologous phase. 
Anti-GBM antibody-induced proteinuria, that is independent of 
complement and PMNs, can be easily induced in guinea pigs. In 
other species it could only be induced after the administra-
tion of very high doses of whole non-complement fixing 
antibody or of F(ab*)2 fragments. The proteinuria in this 
model is transient and, histologic damage does not occur. It 
is generally assumed that the deposition of antibody by 
itself may temporarily perturb the negative charge of the 
glomerular capillary wall, with consequent, increased glome-
rular permselectivity. Complement activation can also direct-
ly cause proteinuria in the absence of PMNs. Evidence for 
such a mechanism stems from observations in PMN-depleted 
rabbits (12) and in C6-deficient rabbits (14). This latter 
study also demonstrated that activation of terminal comple-
ment components is necessary to induce this C-dependent, 
PMN-independent proteinuria. The mechanism of the increased 
glomerular permeability under these circumstances is not 
clear, but it almost certainly involves cytotoxic damage of 
glomerular cells by activation of the complete complement 
pathway. Obviously, an effector mechanism that is dependent 
on PMNs, but not on complement, is also a theoretical option. 
However, such a mechanism has never been observed in experi-
mental models of anti-GBM nephritis. 
A summary of the different mechanisms involved in the protei-
nuria of anti-GBM nephritis is given in Figure 1 (modified 
from Couser et al, réf. 20). Which of these mechanisms 
predominates is dependent on different factors, such as 
animal species, the immunoglobulin class of the antibody, and 
its affinity. However, a very important factor is undoubtedly 
the amount of antibody fixed in the kidney. This has elegant-
ly been demonstrated by Boyce et al (12) , who found that the 
induction of complement-mediated proteinuria in rabbits in 
the absence of PMNs required higher amounts of antibody than 
when PMNs were present. Even higher antibody doses were 
required to induce proteinuria in complement-dependent, PMN-
depleted animals. We have earlier found a similar dose-effect 
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Fig.l Mediator systems in the heterologous phase of anti-GBM 
nephritis (modified from Couser et al, réf. 20) 
relationship in another model of antibody-mediated damage, 
that is, the acute antibody-mediated destruction of skin 
xenografts in the mouse (21). 
It is important to realize that, apart from direct damage to 
the glomerular capillary barrier, induction of anti-GBM 
nephritis is also accompanied by hemodynamic changes. There 
is a marked fall in renal blood flow, which is mainly caused 
by a constriction of the efferent glomerular arterioles. This 
will lead to an increase of the filtration fraction, which by 
itself might increase the loss of protein in the urine. There 
is evidence that this vasoconstrictive effect of anti-GBM 
antibody is complement-mediated (22). 
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Anti-GBM nephritis in the mouse 
The mouse seems an attractive species to study anti-GBM 
nephritis, because its immunogenetic background is well 
mapped and several mediator-deficient inbred strains are 
available. However, until 1985 it was thought that this model 
was not very suitable to study the heterologous phase, since 
it had proven to be difficult to induce histologic lesions 
and reproducible proteinuria during this phase (23-28). 
Recently, we have succeeded in inducing a dose-dependent 
proteinuria in different mouse strains, occurring immediately 
after the injection of rabbit or goat IgG antibody against 
purified mouse GBM (29). Histologically there was immediate 
linear deposition of the injected antibody in the glomerular 
capillary wall and deposition of C3 in a fine granular 
pattern. Large numbers of PMNs invaded the glomeruli and were 
most prominent at 2 h after the injection. When high doses of 
antibody were injected, this was followed by the appearance 
of fibrin thrombi and necrosis of the glomeruli. 
This reproducible model of anti-GBM nephritis in the mouse 
opened a new possibility to carry out detailed studies on the 
role of the mediator systems, that are responsible for the 
proteinuria and the histological lesions. In the studies to 
be reported here, we have explored the role of complement and 
PMNs in the heterologous phase. To that end, we have perfor-
med a series of experiments in animals that were artificially 
depleted of these mediators or that were congenitally defi-
cient. Subsequently, we have studied the effects of PMNs more 
extensively by looking at the role of proteolytic enzymes and 
reactive oxygen metabolites which are released from PMNs 
during their activation and which are considered to be 
important for the eventual tissue damage. 
As mentioned earlier, impressive changes in renal hemo-
dynamics usually occur during the heterologous phase of anti-
GBM nephritis. The influence of changes in renal hemodynamics 
on proteinuria and glomerular damage has recently become a 
field of intensive research. These changes appear to play an 
important role in the progression of renal failure, not only 
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in experimental models of glomerulonephritis, but possibly 
also in the clinical situation. It is of special interest to 
determine if the deleterious effect of these altered hemody-
namic situation can be prevented with drugs. We have, there-
fore, studied whether cyclosporine, a drug with strong 
effects on the renal circulation, can influence the proteinu-
ria in the model of anti-GBM nephritis in the mouse. 
REFERENCES 
1. Lindemann W. Sur la mode d'action de certains poisons 
rénaux. Ann Inst Pasteur 1900; 14: 49. 
2. Masugi M, Tomizuka Y. Über die spezifischen zytotoxi-
schen Veränderungen der Niere und der Leber durch das 
spezifische Antiserum (Nephrotoxin und Hepatotoxin). 
Zugleich ein Beitrag zur Pathogenese der Glomerulo-
nephritis. Tr Jap Path Soc 1931; 21: 329-341. 
3. Masugi M, Sato Y, Mutasawa S, Tomizuka Y. Über die 
experimentelle Glomerulonephritis durch das spezifi-
sche Antinierenserum. Tr Jap Path Soc 1932; 22: 614-
628. 
4. Krakower CA, Greenspon SA. Localisation of the nephro-
toxic antigen within the isolated renal glomerulus. 
Arch Pathol 1951; 51: 629-639. 
5. Kay CF. The mechanism of a form of glomerulonephritis. 
Nephrotoxic nephritis in rabbits. Amer J Med Sci 1942; 
204: 483-490. 
6. Unanue ER, Dixon FJ. Experimental glomerulonephritis. 
Immunological events and pathogenetic mechanisms. In 
Advances in Immunology, edited by Dixon Jr FJ, Humph-
rey JH, New York, Academic Press 1967; 6: 1-90. 
7. Cochrane CG, Unanue ER, Dixon FJ. A role of poly-
morphonuclear leukocytes and complement in nephrotoxic 
nephritis. J Exp Med 1965; 122: 99-116. 
8. Hammer DK, Dixon FJ. Experimental glomerulonephritis. 
II. Immunologic events in the pathogenesis of nephro-
toxic serum nephritis in the rat. J Exp Med 1963; 117: 
1019-1034. 
9. Pilia PA, Boackle RI, Swain RP, Ainsworth SK. Comple-
ment-independent nephrotoxic serum nephritis in Munich 
Wistar rats. Lab Invest 1983; 48: 585-597. 
10. Adler S, Baker PJ, Pritzl P, Couser WG. Detection of 
terminal complement components in experimental immune 
glomerular injury. Kidney Int 1984; 26: 830-837. 
11. Rehan A, Johnson KJ, Wiggins RC, Kunkel RG, Ward PA. 
Evidence for the role of oxygen radicals in acute 
nephrotoxic nephritis. Lab Invest 1984; 51: 396-403. 
12. Boyce NW, Holdsworth SR. Anti-glomerular basement 
membrane antibody-induced experimental glomerulo-
nephritis: evidence for dose-dependent direct antibody 
and complement-induced, cell-induced injury. J Immunol 
1985; 135: 3918-3921. 
13. Cochrane CG, Muller-Eberhard HJ, Aiken BS. Depletion 
of plasma complement in vivo by a protein of cobra 
venom, its effect on various immunologic reactions. J 
Immunol 1970; 105: 55-65. 
14. Groggel GC, Salant DJ, Darby С, Rennke HG, Couser WG. 
Role of terminal complement pathway in the heterolo­
gous phase of antiglomerular basement membrane nephri­
tis. Kidney Int 1985; 27: 643-651. 
15. Wu A, McGinely E, Atkins RC, Holdsworth SR, Thomson 
NM. Glomerular injury induced by a monoclonal antibody 
to rabbit glomerular basement membrane (GBM). Kidney 
Int 1984; 26: 238 (abstract). 
16. Simpson IJ, Amos N, Evans DJ, Thompson NM, Peters DK. 
Guinea pig nephrotoxic nephritis: I. The role of 
17 
complement and polymorphonuclear leukocytes and the 
effect of antibody subclass and fragments in the 
heterologous phase. Clin Exp Immunol 1975; 19: 499-
511. 
Couser WG, Stilmant MM, Jermanovich NB. Complement-
independent nephrotoxic serum nephritis in the guinea 
pig. Kidney Int 1977; 11: 170-180. 
Fantone JC, Ward PA. Role of oxygen-derived free 
radicals and metabolites in leukocyte-dependent 
inflammatory reactions. Am J Pathol 1982; 107: 397-
418. 
Freeman BA, Crapo JD. Biology of disease. Free radi­
cals and tissue injury. Lab Invest 1982; 47: 412-426. 
Couser WG. Mechanisms of glomerular injury in immune-
complex disease. Kidney Int 1985; 28: 569-583. 
Bogman MJJT, Berden JHM, Cornelissen IMHA, Maass CN, 
Koene RAP. The role of complement in the induction of 
acute antibody-mediated vasculitis of rat skin grafts 
in the mouse. Am J Pathol 1982; 109: 97-106. 
Blantz RC, Tucker BJ, Wilson CB. The acute effects of 
antiglomerular basement membrane antibody upon glome­
rular filtration in the rat. The influence of dose and 
complement depletion. J Clin Invest 1978; 61: 910-921. 
Douglas Briggs J, Kwaan HC, Potter EV. The role of 
fibrinogen in renal disease. III. Fibrinolytic and 
anticoagulant treatment of nephrotoxic serum nephritis 
in mice. J Lab Clin Med 1969; 74: 715-724. 
Nagai H, Tahisawa T, Nishiyosi T, Koda A. Experimental 
glomerulonephritis in mice as a model for immunophar-
macological studies. Jpn J Pharmacol 1982; 32: 1117-
1124. 
Nishihara T, Kusuyama Y, Gen E, Tamaki N, Saito К. 
Masugi nephritis produced by the antiserum to hetero­
logous glomerular basement membrane. I. Results in 
mice. Acta Pathol Jpn 1981; 31: 85-92. 
Okada K, Oite T, Kihara s, Morita T, Yamamoto T. 
Masugi nephritis in the nude mice and their normal 
littermates. Acta Pathol Jpn 1982; 32: 1-11. 
Russell PJ, Abbot A, Hicks JD, Muisden К. Electronmi-
croscopy of renal glomerular basement membrane changes 
in healthy mice and in spontaneous and nephrotoxic 
murine nephritis. Pathology 1969; 1: 167-175. 
Unanue ER, Mardiney MR, Dixon FJ. Nephrotoxic serum 
nephritis in complement intact and deficient mice. J 
Immunol 1967; 98: 609-617. 
Assmann KJM, Tangelder MM, Lange WPJ, Schrijver G, 
Koene RAP. Anti-GBM nephritis in the mouse: severe 
proteinuria in the heterologous phase. Virchows Arch 
(Pathol Anat) 1985; 406: 285-300. 


CHAPTER II 
AN IMPROVED SENSITIVE AND SIMPLE MICROASSAY OF MOUSE 
COMPLEMENT 
R.M.W. de Waal, G. Schrijver, M.J.J.T. Bogman, K.J.M. 
Assmann and R.A.P. Koene 
Reprinted by permission from 
The Journal of Immunoloaical Methods 1988; 108: 213-221. 
Copyright 1988 by Elsevier Science Publishers BV (Biomedical 
Division) 

Journal of Immunological Methods, 108 (1988) 213-221 
Elsevier 
JIM 04700 
An improved sensitive and simple microassay 
of mouse complement 
Rob M.W. De Waal ' , Gideon Schrijver 2, M. José J.T. Bogman1 , Karel J.M. Assmann1 
and Robert A.P. Koene 2 
' Department of Pathology and 2 Department of Mediane, Dimston of Nephrology, University Hospital Nijmegen, Nijmegen, 
The Netherlands 
(Received 11 March 1987, revised received 2 October 1987, accepted 16 November 1987) 
A simple and fast hemolytic microassay was developed for the determination of classical pathway 
complement activity in mouse serum The assay is based on hemolysis of sheep red blood cells (SRBC) 
that are sensitized with polyclonal mouse antibodies. The degree of hemolysis was measured in the 
reaction supematants by photometric reading in an ELISA plate scanner at 405 nm wavelength It was 
found that some batches of unpunfied mouse anti-SRBC antibodies gave insufficient hemolysis Analysis 
of two antibody preparations indicated that this might be caused by anti-complementary factors in the 
ascites fluid, and by an excess of non-complement fixing IgGl antibodies. For optimal and standardized 
results, removal of anticomplementary factors and ennchment for complement fixing IgG2 antibodies was 
required and was achieved using protein A purified anti-SRBC IgG In our assay it is possible to 
determine CH50 titers in triplicate in 80 μΐ samples of individual mouse sera with high sensitivity Using 
this rapid one-step method large numbers of tests could be performed in 1 day 
Key words Hemolysis, Complement, mouse, CH50 tiler, Microassay 
Introduction 
Most of the assays developed to measure com­
plement activity in serum make use of antibody-
coated sheep red blood cells (SRBC) as targets for 
complement-mediated lysis. The degree of lysis is 
usually determined by photometry Since these 
assays are frequently not sensitive enough for 
determination of mouse complement activity, 
modifications have been proposed that use other 
red blood cells, such as those of the rabbit, as 
targets, and non-munne immunoglobulins as 
Correspondence to R M W De Waal, Department of Pa­
thology, University Hospital Nijmegen, P O Box 9101, 6500 
HB Nijmegen, The Netherlands 
specific antibodies (Van Dijk et al, 1980, Tanaka 
et al, 1986) However, murine antibodies are pre­
ferable to prevent interfering hemagglutination 
Berden et al. (1978) showed that SRBC can be 
effectively lysed by mouse immunoglobulin and 
mouse complement. In their assays these authors 
used selected 7 S anti-SRBC antibodies, and a 
buffer of 013 M NaCl ю т е strength, and they 
reduced the number of target cells The degree of 
hemolysis was measured by M Cr release. This 
approach had two advantages the occasional con­
siderable background hemolysis in the mouse sera 
no longer interfered with the measurement of 
SRBC hemolysis, and the reduced number of target 
cells improved the sensitivity 
However, for the daily measurements of com­
plement activity in large numbers of sera, this 
0022-1759/88/$03 50 © 1988 Elsevier Science Pubhshers В V (Biomedical Division) 
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method proved to be rather lime consuming and 
the disadvantage of working with radioactive 
material combined with the need to be able to 
measure complement levels in duplicate or trip­
licate in individual mouse sera prompted our 
search for a simpler method To reduce the assay 
time we preferred a one-step incubation of serum, 
antibody and SRBC and determined the lysis pho-
tometncally, using an ELISA plate scanner to 
quantify the results Using this approach both the 
reaction volume and the number of cells could be 
drastically reduced, thus increasing the sensitivity 
of the test The advantages of this microassay are 
(i) rapidity (2-3 h), (n) it requires only 80 μ\ of 
serum, (in) the sensitivity is greatly increased and 
(iv) the use of radioisotopes is avoided 
Using this microassay, we investigated which 
properties of the mouse anti-sheep erythrocyte 
antibody (amboceptor) preparations influenced the 
results and found that the variable results with 
different batches of antibody (frequently observed 
in routine hemolytic assays) are at least in part 
caused by variable amounts of non-complement 
fixing IgGl antibodies which are present in the 
respective batches of amboceptor 
Materials and methods 
Animals 
Inbred lines of BIO D2/new Sn, BIO D2/old 
Sn, C57BL10, A/HeJ, BIO BR and BIO LP mice 
were originally obtained from the Jackson Labora­
tory, Bar Harbor, ME, BALB/c mice from the 
National Institutes of Health, Bethesda, MD, and 
C57BL6/RJJ mice from the Radiobiological In­
stitute TNO, Rijswijk, The Netherlands These 
mouse strains were kept in our animal laboratory 
by continuous brother-sister matings Sheep were 
obtained from a local market 
Mouse anti-sheep erythrocyte antisera (amboceptor) 
Mouse amboceptor was prepared in C57BL6 
and A/HeJ mice by weekly intraperitoneal injec­
tions of 4 Χ 107 SRBC in 0 1 ml 0 9% saline, 
mixed with 0 1 ml complete Freund's adjuvant, for 
at least 5 weeks After this penod the animals 
developed ascites which was tapped weekly The 
samples were pooled, heated at 56 0 С for 45 min, 
centnfuged to remove debns, filtered, and finally 
stenlized by passage through a 0 2 μπι filter The 
hemolytic titer of the ascites fluid was the same as 
that in the serum of these mice The sera were 
stored at - 2 0 ° С 
IgG was isolated from the ascites fluid by affin­
ity chromatography using protein A-Sepharose 
CL-4B (Pharmacia, Uppsala, Sweden) Bound IgG 
was eluted with 0 05 M citrate buffer, pH 2 6, 
containing 1 M NaCl, yielding a fraction ennched 
in the IgG2 subclass of immunoglobulin The IgGl 
subclass was isolated from ascites fluid by affinity 
chromatography using anti-mouse IgGl antibod­
ies coupled to cyanogen-bromide activated Seph-
arose 4B Eluted IgG (IgG2 ennched) and IgGl 
were neutralized with 2 M Tns solution, dialyzed 
against phosphate-buffered saline pH 7 4 (PBS), 
concentrated in an ultrafiltration cell, and sten­
lized by passage through a 0 2 μ m stenle filter 
Sodium azide was added to all fractions in a 0 01% 
concentration 
Immunochemical analysts 
Double immunodiffusion analysis according to 
the method of Ouchterlony (1978) was used to 
determine the presence of immunoglobulins of 
distinct classes and subclasses Goat antisera di­
rected against IgM, IgA, IgG, IgGl, IgG2, IgG2a 
and IgG2b were purchased from Meloy (Spnng-
field, VA) All antisera reacted specifically with 
determinants on the heavy chains of the im­
munoglobulin molecules 
Quantitative determination of the concentra­
tions of immunoglobulins of certain classes or 
subclasses was earned out by the radial immuno­
diffusion technique of Mancini et al (1965) Ciass­
and subclass-specific antisera and IgGl and IgG2 
reference Standards were obtained from Meloy, 
reference standards containing IgM and IgA from 
Litton Bionetics (Kensington, MD) 
Hemagglutination 
Antisera and antibody fractions were tested for 
hemagglutinating activity with SRBC in U-shaped 
microliter plates A doubling dilution senes of 
antibody sample (25 μΐ) was mixed with 25 μΐ 
0 6% SRBC suspension per well, and the results 
evaluated after 2 h incubation at room tempera­
ture 
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Hemolytic assay 
Serum samples of individual mice were ob­
tained by bleeding from the retrobulbar plexus 
After clotting for 1 h at room temperature, serum 
was collected by centrifugation at 4° С and 
ahquots of 100 μΐ of the sera of individual nuce 
were stored at — 70 c С 
For the assay rmcrotiter plates with U-shaped 
wells were used This permitted both determina­
tion of hemagglutination activity and adequate 
centnfugation of SRBC, while the well shape 
avoided rapid accumulation of SRBC at one 
central spot during the hemolytic test All titra­
tions were performed in a dextrose gelatin veronal 
buffer (DGVB2 +) containing 0 15 mM C a 2 + and 
0 5 mM Mg 2 + (pH 7 35), with an ionic strength of 
0 13 M NaCl, prepared according to Rapp and 
Borsos (1970) Stocks of 5% glucose and 5 mM 
veronal-buffered NaCl 0 9%, both containing C a 2 + 
and Mg 2 + were stored at 4 е С These components 
were mixed 1 3 and warmed, and gelatin was 
added freshly from a 10% stock to a final con­
centration of 0 2% SRBC were obtained from 
sheep blood, collected aseptically every 2 weeks in 
an equal amount of Alsever's solution, and stored 
at 4° С Before use, the SRBC were washed four 
times in buffered saline to remove serum and 
white cells, and suspended at a 6% concentration 
in DGVB 2 + After spectrometnc adjustment of 
the concentration, the cells were diluted to 0 6%, 
and this concentration was used in all expen-
ments To each well, containing 40 μ\ solution of a 
doubling dilution senes of the mouse serum to be 
tested, 25 /il amboceptor IgG and 25 /il 0 6% 
SRBC suspension, corresponding to 3 Χ 106 cells, 
were added In standard control senes the am­
boceptor IgG was replaced by 40 μΐ of DGVB 2 + 
buffer The plates were slowly stirred on a vortex 
stirnng machine to resuspend the sedimented 
SRBC, covered and placed in a humid 37° С 
incubator for 90 mm After stirnng and centnfu­
gation at room temperature for 5 mm at 230 X g, 
60 μΐ of supernatant from each well were 
transferred to another rmcrotiterplate (U-shaped) 
This plate was read in a multiscan ELISA reader 
at a wavelength of 405 nm In reference plates 
control sera of untreated normal BIO D2 new and 
congerutally C5-deficient BIO D2 old mice were 
included as positive and negative controls, respec­
tively Additionally, 0% and 100% lysis controls 
were included, by mixing 25 μ 1 of SRBC suspen­
sion with 65 μΐ of DGVB 2 + buffer or 65 μΐ H 2 0 , 
respectively At 100% lysis, £405 values of 0 4-0 5 
were measured For the presentation of the results, 
all values were expressed as percentage of hemoly­
sis The complement activity was expressed as 
CHso U/ml serum, 1 U being defined as the 
amount of complement giving lysis of 50% of the 
SRBC 
Antibody titrations 
To determine the hemolytic activity of an am­
boceptor preparation or a fraction thereof, a senes 
of doubling dilutions of the antibody sample was 
prepared (40 μ 1/well), mixed with 25 μΐ fresh 
BIO D2 new or BALB/c normal mouse serum, 
five-fold diluted (as a source of complement) and 
with 25 μΐ 0 6% SRBC suspension and then in­
cubated for 90 nun and 37° С The results were 
read as indicated above As a control, heat-in-
activated mouse serum (45 mm 56 0 С) or C5-defi-
cient mouse serum were used 
Inhibition assay 
A senes of doubling dilutions of the antibody 
sample to be tested for inhibition activity was 
prepared (40 μΐ/well) To each well 25 μΐ 0 6% 
SRBC suspension was added and binding was 
allowed to occur 1 h at 37° С Subsequently, 25 μΐ 
of hemolytic antibody, two-fold diluted and 40 μΐ 
of fresh mouse serum, diluted ten-fold, were add­
ed and the incubation was extended for another 
hour The degree of hemolysis was determined in 
90 μΐ of supernatant In control plates the serum 
of the initial incubation was replaced by DGVB2* 
Absorption and elution procedure 
For absorption of amboceptor antibodies onto 
SRBC, and subsequent elution we used a modifi­
cation of a previously descnbed method (De Waal 
et al, 1980) Ahquots of 1 ml anti-SRBC ascites 
fluid were mixed with 10 ml SRBC suspension 
(6% v/v) and incubated with gentle stirnng at 
room temperature for 1 h Unabsorbed proteins 
were removed by five washing steps of 15 ml PBS 
per step After this, the absorbed proteins were 
eluted by suspending the sensitized SRBC in 10 
ml elution buffer, consisting of 0 1 M glycine 
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solution, pH 2.6, containing 0.1% BSA. The SRBC 
were pelleted immediately by centrifugation at 
1500 x g for 5 min and the supematants harvested 
and quickly neutralized to pH 7.4 using 2 M Tris 
solution. The eluate was cleared by centrifugation 
(1500 x g, 10 min) and concentrated by ultrafiltra­
tion to a volume of 200 μΐ. 
Results 
Antibody analysis 
From five batches of polyclonal mouse anti-
sheep erythrocyte antiserum we selected the two 
batches with the highest hemagglutination titers, 
assuming that these titers correlate with the hemo­
lytic activity, and we tested these in the antibody 
titration assay for hemolytic activity. One of the 
antisera was produced in A/HeJ mice, the other 
in C57BL6. The results of the titrations, expressed 
as percentage hemolysis, are shown in Fig. 1. 
Using unfractionated ascites as amboceptor, only 
partial hemolysis could be obtained and at the 
lower dilutions an anticomplementary activity was 
present. This unwanted effect was absent when 
the corresponding IgG fractions of the antisera, 
X hemolysis 
80 
60 
τ—ι—ι—ι—ι—ι—ι—г 
l 4 16 64 ( antibody d i l u t i o n )' 
Fig. 1. Antibody titration profiles of anti-SRBC ascites fluids 
produced in A/HeJ and C57BL6 mice ( · · ) and the 
corresponding protein A punfied IgG fractions(0 O). 
isolated from both amboceptor preparations via 
protein A affinity chromatography, were used in 
the same antibody titration assay, and with these 
preparations 100% hemolysis was found (Fig. 1). 
Double immunodiffusion analysis of the two 
ascites preparations indicated that in addition to 
IgG2 both contained considerable amounts of 
IgM, IgA, and IgGl (Fig. 2). Both IgM and IgA 
were lost during the protein A purification proce­
dure, but a restricted amount of IgGl was re-
Fig. 2. Double immunodiffusion analysis of the A/HeJ (AA) and C57BL6 (AC) ascites fluids, and of the A/HeJ protein A eluate 
(PA). The central wells contained 5 μΐ of the test sample and the surrounding wells contained 5 μΐ of the indicated antisera (M: IgM; 
A: IgA; 1: IgGl; 2: IgG2; 2a: IgG2a; 2b: IgG2b). 
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TABLE I 
CONCENTRATION OF IgGl AND IgG2 IN A/He} AND 
C57BL6 MOUSE ANTI-SRBC ASCITES FLUID AND 
FRACTIONS THEREOF 
,_ 1 inhibi t ion 
Preparation (Aggluti- Concentration ± SD (mg/ml) * 
A/He} ascites 
C57BL6 ascites 
A/He] prot. 
A eluate 
C57BL6 prol 
A eluate 
A/He] IgGl 
C57BL6 IgGl 
nation 
tiler) ' 
2048 
4096 
256 
128 
64 
128 
IgGl 
36 6 ±2.0 
4.00±0.33 
0.47 ±0.10 
013±0.01 
131 ±0.17 
0 2 7 ± 0 0 1 
IgG2 
4.15 ±0.43 
4.95 ± 0 5 3 
154 ±0.30 
2 49 ±0.60 
0 11 ±0.01 
0.06 ±0.04 
* Mean ± standard deviations of 3-5 different déterminations. 
tained, as was shown in a radial immunodiffusion 
assay (Table I). The results in Fig. 2 and Table I 
also confirmed that a relative enrichment in IgG2 
relative to IgGl was achieved in this step. 
The high amounts of non-complement-fixing 
IgGl present in the ascites fluids could be re-
sponsible for inhibition of the hemolytic activity 
by blocking the binding of complement fixing 
IgG2 antibodies to the SRBC target antigens. To 
test this assumption IgGl was isolated from both 
ascites fluid batches by affinity chromatography 
using immobilized anti-IgGl antibodies. The pur-
ity of these fractions as determined by radial 
immunodiffusion is shown in Table I, together 
with their activity in the hemagglutination test. 
Both preparations were inactive in the hemolytic 
assay (not shown). The ability of the IgGl frac-
tions to block hemolysis was then tested in an 
inhibition assay using the protein A purified, 
IgG2-enriched fraction as the hemolytic antibody. 
The results are shown in Fig. 3. The hemolytic 
activity of protein Α-purified IgG of both mouse 
strains was inhibited in a dose-dependent fashion 
by the corresponding IgGl fractions. Moreover, 
A/HeJ IgGl could inhibit C57BL6 IgG-mediated 
hemolysis and vice versa. As can be derived from 
the 50% inhibition titers, the A/HeJ IgGl prep­
aration exhibited an approximately four times 
higher inhibitory activity than the C57BL6 IgGl. 
80-
6 0 -
40. 
20-
C57B16 IgG 
\ 
N . 
\.C57BL6 IgGl 
\ 
0GVB** 
C57BL6 
\A/HeJ 
•^,-
іа5 
IgGl 
- I 
A/HeJ IgG A/HeJ IgG 
ι A/HeJ IgGl 
4 16 M 
( Antibody dilution J 
Fig. 3. Inhibition of the hemolysis of protein A-punfied anti-
SRBC IgG by anti-SRBC IgGl The closed dots represent the 
hemolysis after pre-incubauon with IgGl, the open dots give 
control values after pre-incubalion with equal amounts of 
DGVB 2 + buffer. Upper pari. Inhibition of C57BL6 IgG-m-
duced hemolysis. Lower part' Inhibition of A/HeJ IgG-in-
duced hemolysis. All titrations were carried out in duplicate. 
Elution studies 
In our protein A purification procedure we not 
only removed inhibiting anti-complementary fac­
tors and IgGl, but probably also other immuno­
globulin fractions having specific hemolytic activ­
ity on SRBC. To assess the contributions of sep­
arate Ig classes in the specific anti-SRBC activity 
we absorbed aliquots of SRBC suspension with 
A/HeJ and C57BL6 unfractionated ascites fluid, 
and harvested the bound immunoglobulins by acid 
elution. The concentrations of IgM, IgA, IgGl, 
and IgG2 in the eluates were determined by radial 
immunodiffusion. The results are shown in Table 
II. In both SRBC eluates, but especially in the 
A/HeJ eluate, IgGl was the immunoglobulin 
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TABLE II 
ANALYSIS OF THE IMMUNOGLOBULIN FRACTIONS IN THE A/He} AND C57BL6 ASCITES FLUIDS AND SRBC 
ELUATES a 
Immunoglobulin 
class 
IgM 
IgA 
IgGl 
IgG2 
A/HeJ 
Ascites 
0 29 ± 0 01 
0.66 ± 0 02 
36 6 ±2.0 
4 2 ±0.4 
SRBC 
eluate 
0 06 ± 0.00 
0.02 ± 0 00 
11.3 ±0.1 
0.89 ± 0 04 
R" 
4.1 
0.7 
6.2 
4.3 
C57BL6 
Ascites 
1.26 ±0.03 
2 1 3 ± 0 1 1 
4.0 ±0.3 
4 95 ±0.5 
SRBC 
eluate 
0.28 ± 0 01 
0 02 ± 0 00 
0 45 ± 0 01 
0 23 ± 0 01 
R 
4.5 
0.2 
2.3 
0 9 
a
 The iiruminoglobuhn levels were determined in ascites fluids and SRBC eluates in Inplicate using single radial diffusion (Mancini 
et al., 1965). For details see the matenals and methods section. Values are expressed in mg/ml and were calculated as the mean of 
three independent measurements, ± standard deviation 
b
 R, recovery amount of specifically bound immunoglobulins in eluates concentrated X 5, expressed as a percentage of the total 
amount of inununoglobulm of a particular class present in 1 ml of unfraclionaled ascites fluid 
present in highest concentration. This subclass 
was also recovered in high yield, indicating that a 
major part of the anti-SRBC response compases 
non-complement fixing IgGl antibodies. In ad­
dition, IgM and IgG2 were recovered from the 
SRBC in significant amounts. The levels of 
specifically bound IgA in the eluates were very 
low, suggesting that IgA does not contribute sig­
nificantly to the anti-SRBC response. 
Complement titrations 
Complement hemolytic activity was determined 
in the sera of several mouse strains using IgG2-en-
riched protein Α-purified C57BL6 IgG as the he­
molytic antibody. An example of a typical titra­
tion profile is given in Fig. 4, which shows the 
complement titration with fresh B10.D2/new male 
serum. Mouse sera obtained by retrobulbar bleed­
ing often contain considerable amounts of hemo­
globin, which interferes with the measurement of 
hemolysis by extinction. Therefore, the actual 
titration curve was constructed by subtracting the 
extinction values in the control series from the test 
values, thus eliminating background extinction in 
the complement source. Both the extinction values 
and the percentage of hemolysis are indicated in 
Fig. 4. The extinction value that was defined as 
100% hemolysis was determined in the SRBC su­
pernatant that were suspended in H2O. Extinction 
values exceeding 100% hemolysis represented the 
combined extinctions of the lysed SRBC and of 
mouse hemoglobin, present in the test serum. 
Using the Von Krogh equation (Mayer, 1961) the 
amount of CH 5 0 U/ml of mouse serum was 
calculated. Table III gives the CHjo titers found in 
sera of a number of mouse strains. The levels of 
hemolytic activity varied considerably among the 
different strains tested. Of those mouse strains in 
0.5 
0.3 -
0.2 
0.1 
% hemolysis 
- 1 0 0 
16 64 256 
"Τ­
Ι 024 
( serum dilution ) 
Fig. 4 Complement titration profile of BIO D2/new male 
mouse complement. The titration curve ( · · ) was con­
structed by subtracting the blank values (O O) from the 
test values (O O). 100% hemolysis was defined as the 
maximal SRBC lysis in H2O Values higher than 100% were 
caused by the additional extinction of hemoglobin present in 
the lest serum. 
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TABLE III 
HEMOLYTIC COMPLEMENT ACTIVITY IN THE SERA OF MICE OF DIFFERENT STRAINS 
Strain 
Complement normal 
BIO D2 new 
BIO LP 
BIO T(6R) 
BIO BR 
C57BL10 
BALB/c 
BALB/k 
Complement deficient or -depleted 
BIO D2 old 
ATL 
A/HeJ 
ΑΤΗ 
DBA/2 
C57BL10-COVF ь 
(Complement normalv. deficient) FI 
(BIO D2 new χ BIO D2 old) 
(DBA/2 X C57BL10) Fl 
(BALB/c X A/HeJ) Fl 
Fl 
C H
s o
l i l e r ± S D * 
Male 
1 554 ± 244 
1002± 33 
1699 ± 360 
859 ± 161 
1 560 ± 260 
912 ± 178 
1 525 ± 148 
10 
10 
10 
10 
10 
10 
2400 + 377 
1644±409 
ND 
no of animals 
(6) 
(«) 
(6) 
(4) 
(«) 
(6) 
(6) 
(2) 
(3) 
(3) 
(2) 
(2) 
(2) 
(4) 
(4) 
Female 
748 ± 85 
966 ± 164 
N D C 
698 ± 184 
1013 ±145 
654 ± 69 
ND 
ND 
10 
10 
ND 
ND 
ND 
344 ±118 
N D 
305 ± 66 
no of animals 
(6) 
(6) 
(6) 
(6) 
(6) 
(3) 
(3) 
(4) 
(2) 
' Expressed as U/ml 
b
 C3 depleted by treatment with ι ρ injections of 20 U CoVF (Cordis Laboratones, Miami, FL) 26 h and 2 h before serum sampling 
c
 Not determined 
which both female and male animals were tested, 
the males showed higher levels of complement 
activity. In sera of strains known to lack the C5 
complement component (Nilsson and Muller-
Eberhard, 1967) no hemolytic activity exceeding 
the detection threshold of 10 U/ml was found 
C57BL10 mice that were C3 depleted by treat­
ment with cobra venom factor (CoVF) were also 
negative for serum complement hemolytic activity 
In hybrids of C5-deficient and C5-positive strains, 
the male mice showed normal to high complement 
activity, while in the female hybrids decreased 
values were found 
Discussion 
We have developed a simple, fast and sensitive 
assay for the determination of classical pathway 
hemolytic activity of mouse complement The as­
say was based on the hemolysis of SRBC by 
polyclonal mouse anti-SRBC antibodies and 
mouse complement, and was modified from a 
complement assay described by Berden et al 
(1978) The use of mouse immunoglobulin for the 
sensitization of SRBC had the advantage that it 
caused less unwanted hemagglutination than non-
munne antibodies However, the relative amounts 
of different antibody classes in the hemolytic am­
boceptor were also of major importance, since the 
lytic activity largely depended on the presence of 7 
S anti-SRBC IgG Berden et al (1978) increased 
the sensitivity of their assay by using a low ю т е 
strength in the reaction medium, low numbers of 
SRBC and a small test volume In the present 
assay we have reduced the number of SRBC per 
test well to 3 X 106, and the total reaction volume 
to 90 μΐ Under these circumstances un-
fractionated amboceptor preparations cause only 
partial hemolysis (Fig 2) This can be due to three 
causes, a low content of 7 S IgG, the presence of 
anti-complementary factors, or an excess of non-
complement-fixing IgGl antibodies blocking the 
binding of complement fixing IgM or IgG2 Pun-
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fication of IgG by protein A affinity chromatogra-
phy deals with all three causes 7 S IgG is prefer-
entially isolated, anti-complementary factors are 
removed, and the IgG2 IgGl ratio is substan-
tially increased On the other hand, the same 
procedure will also remove the IgM fraction that 
can play a role in the hemolytic activity as com-
plement-binding antibody However, this loss of 
specific activity appears to be limited and con-
sistent with the findings of Berden et al (1978) 
who showed that 19 S mouse amboceptor antibod-
ies had only restricted hemolytic activity if used in 
combination with mouse complement Moreover, 
the removal of anti-complementary factors and of 
blocking IgGl antibodies more than compensate 
for the loss of the IgM fraction That the IgGl 
antibodies can indeed act as blocking antibodies 
for the hemolytic IgG2 fractions was shown in the 
inhibition assay Despite some loss of specific 
hemolytic components, the removal of the inhibit-
ing components from the original ascites fluid 
resulted in an amboceptor preparation that gave 
reproducible values in our complement titration 
assay, with a sigmoid titration curve and high 
sensitivity 
In the immunochemical determinations only 
the total amount of immunoglobulin class or sub-
class proteins is measured, and it is not known 
which fraction contains the specific anti-SRBC 
antibodies It is therefore not justified to consider, 
for example, the total IgGl content of the A/HeJ 
and C57BL6 IgGl fractions as an indicator of the 
inhibitory activity The results of the elution ex-
periments provide a better indication for this, and 
show that the A/HeJ IgGl has a somewhat higher 
specific activity than C57BL6 IgGl, which, to-
gether with the higher IgGl protein concentration 
in the A/HeJ preparation, is in agreement with 
the approximately four-fold higher inhibitory 
capacity of the A/HeJ IgGl (Fig 3) The elution 
experiments also show that anti-SRBC IgM and 
IgG2 antibodies are present, but in both ascites 
fluids most anti-SRBC antibodies are of the non-
complement fixing IgGl subclass Removal of 
these latter antibodies seems, therefore, even more 
appropriate Since only a negligible amount of 
IgA was found in the SRBC eluates, this antibody 
class seems to play no important role in the anti-
SRBC response, and the removal of IgA antibod-
ies will have few consequences for the subsequent 
hemolytic activity 
The removal of anti-complementary and inhibi-
tory factors from the amboceptor preparations 
permitted us to omit a separate sensitization and 
washing step pnor to addition of the complement 
source, thus greatly simplifying the procedure 
However, in a one-step incubation, background 
hemolysis, which is a common feature of mouse 
sera, is not removed from the test medium The 
extinction values for every serum dilution were 
therefore corrected by subtracting control values 
that were measured in reaction supernatants in 
which the amboceptor was replaced by DGVB2 + 
buffer Fig 4 shows that this procedure gives a 
good result, as is indicated by the flat plateau of 
maximal hemolysis 
Our assay measures the complement activity of 
the classical pathway, although activation of alter-
native pathway components leading to hemolysis, 
cannot be completely excluded However, this 
phenomenon generally occurs at high serum con-
centrations (Van Dijk el al , 1980, Tanaka et al, 
1986) and will therefore play no role in the hemo-
lytic activity observed in our test system 
We found substantial differences in comple-
ment activity in the sera of mice of the various 
strains Variations in complement levels and the 
relation of this phenomenon to the Ss-Slp pheno-
type and the H-2 halotype of the inbred mouse 
strains have been described by Demani et al 
(1973), and our results confirm these observations 
In our assay all male sera showed higher activity 
than female, which was also found by others (Terry 
et al, 1964) The CH50 titers of the sera of three 
different hybrids of C5-deficient and C5-normal 
strains show that in male hybnds the C H ^ levels 
are comparable to those in the C5-positive parent 
strain In female hybrids, however, considerably 
lower C50 titers than those in the C5-positive 
parents were measured The discrepancy may be 
caused by the low expression in the Sip" product 
in female mice (Passmore and Shreffler, 1971) and 
is probably related to the complement component 
C4 (Klein, 1982) 
In conclusion, our findings demonstrate that 
the use of protein A-punfied IgG2-ennched mouse 
amboceptor IgG, together with the other modifi-
cations in the test conditions, such as the reduced 
30 
SRBC concentration and reaction volume, as well 
as the use of the microliter plate scanner for the 
determination of hemolysis, have resulted in a 
reliable, simple, and rapid method for the titration 
of complement activity in mouse sera, that com­
bines very high sensitivity with very small reaction 
volumes. 
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Antiglomerular Basement Membrane Nephritis 
in the Mouse 
Study on the Role of Complement in the Heterologous Phase 
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The role of complement was examined in a model of antiglomerular basement membrane 
nephritis in the mouse, induced by intravenous injection of goat anti-mouse glomerular basement 
membrane serum, and characterized by early glomerular lesions and a dose-dependenl albuminu­
ria. We compared the reaction after injection of the antiserum in complement-normal B10.D2 new 
mice with that in congenie, congenitally C5-deficient B10.D2 old mice, and in both strains after 
C3 depletion by treatment with cobra venom factor. The dose-dependent albuminuria was not 
affected by the absence of complement activation. Also, deficiency of C3 and/or C5 had no inhibitory 
effect on the histologic glomerular lesions: it did not reduce the influx of polymorphonuclear 
granulocytes in the glomerular capillary vessels, nor prevented the eventual intravascular coagu­
lation. We conclude that complement-independent mechanisms are involved in the development of 
the heterologous phase of antiglomerular basement membrane nephritis in the mouse. 
Additional key words: Albuminuria, Cobra venom factor. 
Among the experimental models, developed to study 
the pathogenesis of immunologically induced glomeru­
lonephritis, the model of antiglomerular basement mem­
brane (anti-GBM)-nephritis that is induced by injection 
of anti-GBM antibodies, is one of the first and most 
extensively studied (11, 37, 39) The morphology of the 
early glomerular lesion is that of an acute inflammation, 
with immediate deposition of the injected antibody to­
gether with complement along the GBM, followed by 
accumulation of polymorphonuclear granulocytes 
(PMNs) in the capillary vessels After 5 to 7 days, this 
early heterologous phase is followed by an autologous 
phase, in which host antibodies, produced against the 
injected proteins, bind to the deposited heterologous 
immunoglobulins Both the heterologous and the autol­
ogous phase of the anti-GBM nephritis are accompanied 
by proteinuria 
Most studies have concentrated on the role of comple­
ment factors and PMNs in the early heterologous phase, 
that can be induced easily and with good reproducibility 
in rats and rabbits For studies on the role of comple­
ment, two main approaches have been chosen one is the 
use of complement-depleted or congenitally complement 
deficient animals, the other the use of noncomplement 
fixing antibodies Using the first approach, in which anti 
kidney or anti-GBM antibodies were injected in compie 
ment-depleted rats or rabbits, several authors found that 
the development of anti GBM nephritis was inhibited 
(14, 22-24) From the finding that PMN depletion had a 
similar effect, it was concluded that complement in the 
immune vasculitis of anti-GBM nephritis served as a 
chemoattractant for PMNs, which by release of their 
lysosomal enzymes and oxygen-radicals caused the even­
tual damage (10, 13, 32) A critical role especially for 
terminal complement factors in the heterologous phase 
of anti-GBM nephritis was also reported by Groggel et 
al (21) who used C6-deficient rabbits However, other 
authors, either using a similar approach, or working with 
noncomplement-fixing antibodies, found the develop­
ment of the proteinuria in the heterologous phase of 
anti-GBM nephritis in different species to be independ­
ent of complement activation (reviewed in reference 16) 
Our incomplete insight in the pathogenetic mecha­
nisms of glomerular damage is partly due to the conflict­
ing findings in different systems, in which the results 
seem greatly dependent on the animal species used, and 
on the amount, source, and class of antibodies (reviewed 
in reference 37) To elucidate some of the discrepancies 
found in the role of mediator systems in the heterologous 
phase of the anti GBM nephritis in different species, we 
developed a model of anti-GBM nephritis in the mouse. 
This species has the advantage of the availability of 
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many inbred strains, including congemtally complement-
deficient varieties (28), that can be used with congenie 
complement-normal strains serving as controls 
Previous attempts to induce anti-GBM nephritis in 
the mouse have been more or less unsuccessful, either 
because the heterologous phase developed only slowly, 
with no clear distinction from the autologous phase, or 
because there was no good dose response relationship (2, 
6, 18, 20, 25, 27, 29, 30, 34, 38) In our model we were 
able to induce an acute, early developing, dose depend­
ent, and reproducible heterologous phase of anti-OBM 
nephritis in mice by intravenous injection of goat or 
rabbit anti-mouse GBM antibody (3) The present report 
describes the role of complement in the development of 
albuminuria and glomerular lesions in this model, com­
paring the effects of intravenous injection of goat anti-
mouse GBM antibody in BIO D2 new mice and in con­
geme, congemtally CS-deficient BIO D2 old mice In ad­
dition the effect of C3 depletion by treatment with cobra 
venom factor (CoVF) was studied in both strains 
EXPERIMENTAL DESIGN 
To determine the kinetics of the glomerular protein 
leakage and the optimal time for urine sampling, we 
measured the albumin concentrations in urine obtained 
by bladder puncture at 2, 4, 6, 8, 12, 24, and 48 hours 
after injection of 7 5 mg of goat anti-mouse GBM anti­
body in B10.D2 old mice Subsequently, a dose response 
study was performed in groups of otherwise untreated 
BIO D2 new and BIO D2 old mice, that received increas­
ing amounts of goat anti-mouse GBM serum The re­
sulting albuminuria was measured in 18-hour urine sam­
ples collected in the time interval between 6 and 24 hours 
after the injection of the goat anti-mouse GBM anti­
serum During this time the mice were placed in individ­
ual metabolic cages, and received only tap water ad 
libitum. Since most mouse strains show a spontaneous 
proteinuria, we determined the physiologic levels of al 
buminuna in 60 normal B10D2 new and BIO D2 old 
mice These were found to be 31 ± 12 tig and 21 ± 10 Mg 
albumm/18 hours (mean ± SD) respectively Albuminu­
ria was considered pathologic when it exceeded a value 
greater than the mean of untreated BIO D2 new mice 
plus two standard deviations, ι e, when it was higher 
than 55 Mg albumm/18 hours 
To study the role of complement, we tested the effect 
of treatment with CoVF in groups of BIO D2 new and 
BIO D2 old mice that were injected with a low (1 9 mg) 
and a high (7 5 mg) dose of goat anti-mouse GBM serum 
Mice of both strains, injected with 1 9 mg and 7 5 mg of 
normal goat Ig, and mice treated with daily injections of 
20 units of CoVF only, served as controls In all groups 
18-hour urine samples were collected 1 day before injec­
tion of the antiserum and on days 1 and 4 thereafter For 
histologic examinations, the kidneys of at least three 
mice were sacrificed at 2 hours, 24 hours, and 4 days 
after injection of the anti-GBM serum 
COMPLEMENT DEPLETION 
C3 depletion was induced by daily intraperitoneal in­
jection of 20 units of CoVF (Cordis Laboratories, Miami, 
Florida) for 5 days, starting 24 hours before injection of 
goat anti mouse GBM antiserum This dose regimen 
lowers serum hemolytic complement activity to unmea-
surable levels from 24 hours after the first injection 
Using a sensitive hemolytic assay as described by Berden, 
Hagemann, and Koene (5) we found that serum comple­
ment activity in the CoVF-treated BIO D2 new mice 
remained unmeasurable throughout the time of the ex­
periments The complete deficiency of hemolytic comple­
ment activity in the BIO D2 old strain was confirmed by 
the same technique CoVF treatment as such did not 
induce albuminuria in either strain On the day of injec­
tion of anti GBM antibody, CoVF was administered 
simultaneously with the antiserum. 
RESULTS AND DISCUSSION 
In these short-term experiments the mice sustained 
all procedures in good condition None of the mice de 
ν eloped anaphylactic symptoms after the injection of 
various amounts of antibodies, or during administration 
of CoVF During the 18-hour residence in the metabolic 
cages, the mice showed a weight loss of about 10% and a 
lowering of skin temperature, but otherwise no undesir­
able side effects Serum concentrations of albumin, urea, 
and creatinine showed only slight fluctuations and there 
were no signs of renal failure or nephrotic syndrome 
(Table 1) 
The kinetics of the albuminuria as determined by-
bladder punctures at closely spaced intervals after injec­
tion of antiserum are shown in Figure 1 Enhanced 
excretion of albumin was first observed between 2 to 4 
hours and reached a maximum at 12 hours Based on 
these findings, mice were placed in metabolic cages from 
6 to 24 hours after injection of antiserum Table 2 shows 
the albuminuria after increasing doses of goat anti-mouse 
GBM antibodies as determined in 18-hour urine samples 
in BIO D2 new mice, BIO D2 old mice, and BIO D2 new 
mice treated with CoVF The variation in albuminuria 
in the group is relatively large, which is probably related 
to a combination of variations in individual responses 
and sampling errors Despite this, in both strains the 
degree of albuminuria appeared to be highly dependent 
on the amount of antibody given Pathologic albuminuria 
could be induced with a dose of 0 9 mg and it increased 
with higher doses The levels of albuminuria in BIO D2 
new mice were always higher than those in BIO D2 old 
mice and significantly different from these after doses 
from 1 9 through 7 5 mg of antiserum At day 4, all 
groups showed albuminuria that was 20 to 60% lower 
than that at day 1 
Considering the differences in age and sex-matched 
BIO D2 new and BIO D2 old mice we originally assumed 
that the complement deficiency in the BIO D2 old strain 
was probably a major factor However, Table 2 also shows 
that depletion of C3 by CoVF treatment of BIO D2 new 
mice did not significantly influence the amount of albu­
minuria, except that occurring after injection of the low 
dose of 0 9 mg When we treated both BIO D2 new and 
BIO D2 old mice with CoVF and injected both strains 
with a low and a high dose of antibody (1 9 and 7 5 mg) 
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we also found that C3 depletion had no significant effect 
on the albuminuria neither in the complement-normal 
nor in the Co-deficient strain (Fig. 2). In these experi­
ments, CoVF treatment led to unmeasurably low CH50 
levels. Excessive regimens of C3 depletion consisting of 
double doses of CoVF, or daily CoVF treatment starting 
3 days before injection of antibody, also failed to decrease 
the albuminuria in either group (data not shown). 
To exclude a strain dependency we studied the effect 
TABLE 1. S E R L M ALBUMIN, UREA, AND CREATININE 
CONCENTRATIONS IN B 1 0 D 2 N E W M I C E AT DAY 1 AFTER 
INJECTION OF GOAT A N T I - M O U S E GBM ANTIBODY WITH OR 
WITHOUT C O V F TREATMENT"* 
Dose of 
antibody CoVF Albumin Urea Creatinine 
mf 
1 9 
1.9 
_ 
— 
-
+ 
-
+ 
g/l 
29 + 1 
26 ± 1 
25 ± 1 
27 ± 1 
mmul/l 
9.2 ± 1.7 
9 2 ± 0.7 
9 6 ± 0.9 
114 ± 0 7 
μΙΠΟΐ/Ι 
35 ± 2 
30 ± 1 
29 ± 7 
36 + 4 
" Comparable results were obtained after injection of 7 5 mg of goat 
anti-mouse GBM antibody and in BIO D2 old mice with either dose of 
antibody. 
b
 Means ± SD in three mice/observation point. 
of CoVF on the glomerular protein leakage after injection 
of the antiserum in C57BL10 mice. Also in this strain 
we did not observe any influence of CoVF treatment on 
the degree of albuminuria after injection of 1.9 mg (619 
± 387 ßg in 7 CoVF-treated versus 860 ± 409 /ug albumin/ 
18 hours in 18 nonCoVF-treated mice) or 7.5 mg of 
antiserum (8,601 ± 4,857 μξ in 18 CoVF-treated versus 
8,377 ± 2,281 ßg albumin/18 hours in 9 non-CoVF-
treated mice). 
HISTOLOGY 
Binding of the anti-GBM antibody to normal mouse 
kidney was tested by in vitro incubations of kidney 
sections in an indirect immunofluorescence technique. 
There was a linear staining of glomerular and tubular 
basement membranes. In immunoelectron microscopy, 
the binding was predominantly localized in the GBM 
proper. The adjacent cell membranes of the endothelia 
and epithelia showed a faint binding, but the membranes 
of cells not immediately adjacent to the site where the 
reaction product of the diaminobenzidine substrate was 
generated, were completely negative (Fig. 3). Control 
incubations with non-immune goat Ig did not reveal any 
staining of glomeruli and tubuli. It can be concluded that 
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FIG 1 Albuminuria in B10.D2 old mice after injection of 7 5 mg of 
goat anti-mouse GBM antibody Albumin concentralions (mean ± SD; 
N = 3) were determined in urine samples obtained by bladder puncture. 
Albuminuria ( ¿ j g / l ß h ) 
10,000 
800O-
• G a M - GBM 
—
 GaM-GBM »CoVF 
Physio logic alDuminuna 
FIG 
1 9 mg 7 5 mg 
2. Albuminuria after administration of 1 9 mg and 7 5 mg of 
goat anti-mouse GBM {GaM-GBM) antibody with and without treat-
ment with CoVF in BIO D2 new and BIO D2 old mice Albuminuria is 
given as total amount of albumin in urine samples collected between 6 
and 24 hours after injection of antibody (mean ± SD) 
T A B L E 2. ALBUMINURIA AFTER INJECTION OF INCREASING AMOUNTS OP GOAT A N T I - M O U S E GBM ANTIBODY IN B10D2 N E W AND 
B10D2 OLD MICE AT DAY 1 
antibody 
mg 
0.5 
0.9 
1.9 
3.8 
7.5 
15 
BIO D2 old 
36 ± 10 (6) 
214 ± 166 (6) 
551 ± 250 (14) 
1783 ± 1178 (6) 
4127 ± 1909 (18) 
8028 ± 6503 (6) 
P' 
NS 
NS 
< 0 001 
<0 001 
<0 001 
NS 
Mean albuminuria ± SD (μρ/ΐβ hr) 
BIO D2 new 
46 ± 14 (6) 
461 ± 338 (16) 
1248 ± 453 (19) 
5979 ± 2674 (6) 
10484 ± 5460 (27) 
1374S±5441 (11) 
P" 
N S 
< 0 05 
N S 
N S 
N S 
NS 
BIO D2 new + 
CoVí-
Sl ± 12 (6) 
208 ± 180 (6) 
1565 ± 894 (22) 
4182 ± 235 (6) 
10227 ± 3830 (12) 
16304 ± 7709 (6) 
"p values indicating the statistical significance of the difference between the values in the adjacent columns, NS, not significant Number of 
mice in parentheses 
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the major population of antibody in the polyclonal anti-
GBM serum reacts with constituents of the GBM. 
LIGHT MICROSCOPY 
Injection of 7.5 mg of antiserum induced an early and 
prominent influx of PMNs in the glomeruli of both the 
B10.D2 new and B10.D2 old mice, at 2 hours after 
injection (Table 3 and Fig. 4). This PMN influx quickly 
subsided to normal values at 24 hours and remained at 
these levels until the end of the experiment. The PMN 
influx in B10.D2 old mice was even slightly higher than 
that in B10.D2 new mice, but this difference was not 
significant. 
Table 3 also shows that depletion of C3 in both strains 
of mice by treatment with CoVF did not influence the 
extent of PMN accumulation. Apart from the PMN 
influx there was swelling of endothelial cells in the 
capillary loops and, from 2 hours, focal, small thrombotic 
lesions were present. At days 1 and 4 many glomeruli 
showed advanced segmental or global thrombosis and 
necrosis accompanied by segmental swelling of epithelial 
cells. Like the PMN influx, these changes were not 
affected by C5 deficiency or CoVF treatment. The injec-
tions of low doses of antiserum (1.9 mg) showed com-
parable effects: all mice had glomerular lesions that were 
similar in complement-normal, CS-deficient and in C3-
depleted groups. The influx of PMNs with this dose of 
antiserum was slightly less than that with doses of 7.5 
mg (Table 3). 
Kidneys of control groups, that had received either 
nonimmune goat Ig or CoVF alone, showed no morpho-
logic changes. The numbers of glomerular PMNs at 2 
hours were only slightly higher than those in normal 
mice, probably as a consequence of an increase of circu-
lating PMNs, occurring both after injection or normal 
goat Ig and of CoVF alone (Table 4). 
IMMUNOFLUORESCENCE 
The essential immunohistologic findings are summa-
rized in Table 5. Two hours after administration of 7.5 
mg of goat antibody, linear deposits of goat Ig were 
observed along with fine granular binding of C3 in the 
glomerular capillary wall in both the B10.D2 new and 
the B10.D2 old mice (Fig. 5A and ß ) . The amount of 
deposited goat Ig, as estimated semiquantitatively, re-
mained unaltered during the 4 days of the experiments 
in all groups. However, the binding of C3 in the capillary 
wall was transient. It had considerably decreased at day 
1 and was hardly visible at day 4. Depletion of C3 by 
CoVF treatment completely prevented binding of anti-
C3 in glomerular capillary wall and mesangium in both 
the complement-normal and C5-deficient mice (Fig. 5C). 
T A B L E 3 INFLUX OF P M N s IN G L O M E R U L I AT 2 HR AFTER 
I N J E C T I O N OF G O A T A N T I - M O U S E GBM ANTIBODY IN B10D2 
N E W AND B10.D2 O L D M I C E 
Intravenous 
injection of 
Anti-GBM 
Anti-GBM 
Anti-GBM 
A n t i G B M 
Normal goat Ig 
Normal goat Ig 
NaCl 0.9% 
NaCl 0.9% 
No t reatment 
Dose 
1.9 mg 
1.9 mg 
7.5 mg 
7.5 mg 
1.9 mg ' 
7.5 mg ' 
0,3 m l ' 
0,3 m l ' 
CoVF 
treatment 
-
+ 
-
+ 
-
-
-
+ 
-
Number of PMNs/glomerulus" 
B10.D2 new 
3.9 ± 1.2 (3) 
3.5 ± 1 . 1 (6) 
5.0 ± 0.6 (3) 
5.0 ± 0.7 (3) 
0.4 ± 0.1 (3) 
0.6 ± 0 . 1 (3) 
0.1 ± 0 . 1 (6) 
0.2 ± 0.1 (3) 
0.1 ± 0.1 (61 
BIO D2 old 
4.3 ± 1.2 (3) 
4.5 ± 0.2 (3) 
5.3 ± 1.8 (5) 
5.8 ± 1.0 (3) 
0.4 ± 0.1 (3) 
0.4 ± 0.2 (3) 
0.1 ± 0.0 (6) 
0.2 ± 0.0 (3) 
0.1 ± 0.0 (6) 
" Numbers of P M N s were counted in 40 glomeruli of each mouse 
and are given as mean ± SD/glomerulus. Number of mice In parenthe-
ses. 
* Control mice received nonimmune goat Ig (G.Ig), 0.3 ml NaCl 0.9% 
or no treatment. 
?m^% 
FiG. 3. tmmunoelectron micrograph of a glomerular capillary loop 
of a normal mouse kidney. Cryostat sections were incubated with goat 
anti-mouse GBM antibody and peroxidase-labeled rabbit anti-goat Ig 
antiserum to visualize bound goat Igs. Reactivity is predominantly 
localized in the GBM proper, although some reaction product of the 
diaminobenzidine substrate is also present on adjacent cell membranes 
of the endothelium and epithelium. Regions of the cell membranes 
more remote from the GBM are negative (arrou;). x8,500. 
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F I G . 4. Influx of polymorphonuclear granulocytes in glomerulus at 
2 hours after injection of 7.5 mg of goat anti-mouse GBM antibody. 
Periodic acid-Schiff, x640. 
T A B L E 4. N U M B E R S o r C I R C U L A T I N G P M N S IN B10.D2 N E W 
AND B10.D2 O L D M I C E AT 2 H R AFTER I N J E C T I O N O F G O A T 
A N T I - M O U S E G B M S E R U M , G O A T I G , AND C O V F 
Intravenous injection CoVF 
PMNs X 10-"/1 1 SD 
1 . 9 m g G a M . G B M 
1.9 mg GaM.GBM 
1.9 mg Goat Ig 
None 
None 
2719 ± 8 1 2 (10) 2116 ± 7 1 6 (6) 
2940 ± 868 (10) 2462 ± 778 (6) 
2532 ± 556 (6) 
+ 2718 ± 1040 (9) 
1 1 1 1 + 4 9 5 ( 1 0 ) 
2631 ± 1025 (6) 
1715 ± 319 (6) 
838 ± 3 8 3 (10) 
Number of mice in parentheses. 
T A B L E 5. I M M U N E R E A C T A N T S D E P O S I T E D IN T H E G L O M E R U L A R 
CAPILLARY W A L L A F T E R I N J E C T I O N O F 7.5 MG O F G O A T A N T I -
M O U S E GBM A N T I B O D Y IN B10.D2 O L D M I C E WITH AND 
W I T H O U T C O V F T R E A T M E N T " 
Time al 
injection 
2 
24 
96 
ter 
(hr) CoVF 
-
+ 
-
+ 
-
+ 
Goat 
Ig' 
+ + + + 
+ + + + 
++++ 
++++ 
+ + + + 
++++ 
Mouse 
IT 
-
-
-
-
-
-
Mouse 
СЗ" 
+ + 
-
+ 
-
-
-
Fibrin 
± 
± 
+ + 
+ + 
+/++ 
+/++ 
" Identical results were obtained in B10.D2 new mice. All data given 
as mean findings in glomeruli of three mice per point. 
* Linear staining in the capillary wall. 
c
 Small amounts of mouse Ig and C3 in the mesangium, a normal 
finding in these mouse strains, were neglected. 
d
 Fine granular staining in the capillary wall. 
At 2 hours sporadic, small fibrin thrombi were seen in 
capillary loops or mesangium. At 24 hours these were 
present in more than 50% of the glomeruli, comprising 
many or all glomerular loops. A similar picture was seen 
at 4 days (Fig. 5D). Depletion of complement activity by 
CoVF treatment or deficiency of C5 in the B10.D2 old 
mice had no effect on the first appearance or the extent 
of the fibrin deposits. In glomeruli of mice injected with 
1.9 mg of goat antibody, the deposits of goat Ig, mouse 
C3, mouse Ig, and fibrin, were less extensive. In control 
groups that had received nonimmune goat Ig, none of 
the mice showed glomerular deposits of goat Ig, mouse 
C3, or fibrin. 
D I S C U S S I O N 
In contrast to the findings in the extensively studied 
classical models of anti-GBM nephritis in rabbits and 
rats, our results show that in our murine model comple­
ment does not play a major role in the induction of the 
glomerular lesions or the albuminuria of the early het­
erologous phase. We did find some fixation of C3 in the 
glomeruli of complement-normal and CS-deficient mice, 
but it was transient and showed a fine granular pattern, 
whereas in the rat, a strong linear binding is seen that 
remains present for a prolonged period of time (36). 
Complete C3-depletion, as evidenced by the disappear­
ance of measurable hemolytic complement activity from 
the serum, and the total absence of C3 deposits in the 
glomeruli, did not have any inhibitory effect on either 
the histologic lesions or the severity of the albuminuria. 
CoVF can induce or enhance proteinuria in rats when it 
is injected directly into the renal artery (33). This is 
most likely caused by local complement activation with 
accompanying damaging effects directly in the kidney. 
In our model, such a direct effect is not likely, since 
systemic complement depletion was induced by CoVF 
treatment starting 24 hours before the injection of anti­
body. Indeed, in control groups, intraperitoneal injection 
of CoVF alone did not induce a pathologic albuminuria. 
At first sight, the consistently lower albuminuria found 
in the C5-deficient B10.D2 old strain compared with that 
in B10.D2 new mice suggests a complement dependency 
and seems to be conflicting with the results obtained 
after CoVF treatment in B10.D2 new mice. One could 
argue that CoVF treatment does not induce complete C-
depletion at the local level, which would leave room for 
a role of terminal complement components in B10.D2 
new mice, but not in the C5-deficient B10.D2 old strain. 
This explanation seems unlikely since there was no trace 
of C3 deposition in the glomerular capillary wall in 
CoVF-treated animals. Possibly, the congenie inbred 
B10.D2 new and B10.D2 old strains differ not only in 
complement activity, but also in other unknown geneti­
cally defined factors that determine the extent of albu­
minuria after administration of the goat anti-GBM an­
tibody. There are two other reports on the induction of 
anti-GBM nephritis in B10.D2 new and old mice (25, 
38). In these studies no or only small differences in the 
histologic lesions between both strains were found, but 
they only dealt with the late, autologous phase, and 
provide no information pertinent to our study of the 
early, heterologous phase. 
Our findings indicate that, although the sequence of 
events after injection of the anti-GBM antibody in the 
mouse is similar to that in the classical models in rats 
and rabbits, the pathogenetic mechanisms must be dif­
ferent. They cannot be explained by either of the two 
main pathways of complement-mediated tissue destruc­
tion, i.e., the chemotactic effect of C5a and other com-
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FIG. 5. A to D, Immunofluorescence findings after injection of 7.5 
mg of goat anti-mouse GBM antibody in B10.D2 new mice. A, Linear 
binding of the injected goat immunoglobulins to the glomerular capil-
lary wall at day 1. B, Mouse C3 is transiently present along the capillary 
plement factors, inducing tissue damage by released ly-
sosomal enzymes and oxygen radicals of attracted PMNs, 
or a direct lytic effect on cells or membranes brought 
about by the membrane attack complex C5-C9. 
Apart from the classical complement-dependent forms, 
several other models have been described in which com-
plement-independent mechanisms can directly cause al-
buminuria in the early phase of anti-GBM nephritis 
(reviewed in reference 16). In some of these models, 
noncomplement-fixing antibodies or F(ab')2 fragments 
were used, or complement-fixing antibodies were injected 
in complement-deficient or complement-depleted ani-
mals (13,16). In other models, local complement fixation 
did not take place due to unknown factors (1,17, 31, 35). 
In most of these studies, the result of injection of anti-
GBM serum was a massive but transient increase of 
wall in a fine granular or homogenous pattern at 2 hours. C, No C3 is 
seen in glomerular capillaries of CoVF-treated mice. D, Massive fibrin 
deposits are present at day 4. X640. 
glomerular permeability without signs of local comple-
ment deposition and without accumulation of PMNs in 
the capillary loops. That anti-GBM antibody by itself 
can enhance glomerular permeability was recently con-
firmed in an isolated perfused kidney model (9, 15). It is 
thought that the binding of antibody results in an inter-
nal alteration or distortion of the geometry of the filtra-
tion barrier, leading to an increased leakage of protein. 
In reviewing the different models of anti-GBM ne-
phritis, it appears that the proteinuria can be brought 
about by at least three factors: deposition of antibody as 
such, activation of complement, and damage by cellular 
influx. Boyce and Holdsworth (8) demonstrated that it 
can be the quantity of antibody deposited in the glomer-
ular wall that determines which mediator systems be-
come involved. Gradual increasing of the amount of 
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antibody subsequently set in motion three mechanisms 
of renal injury at low doses, the well established comple­
ment and P M N dependent mechanism was activated, 
requiring the activation of early complement compo 
nents At higher doses, a complement dependent, but 
P M N independent mechanism became also operative, 
for which activation of terminal complement components 
might be crucial At the highest dose, a direct antibody 
mediated injury could be demonstrated 
We cannot exclude that in our murine model the 
albuminuria was caused by a direct action of the antibody 
itself However, inflammatory changes were very promi­
nent and occurred at 30 minutes after injection of the 
antibody, both in complement normal and in C5 defi­
cient or C3-depleted mice The conspicuous presence of 
P M N s in the early stages preceding the development of 
the albuminuria, points to these cells as likely candidates 
for inducers of the ultimate damage Since there is no 
significant difference in the numbers of P M N s in com 
plement normal and complement deficient or C3 de­
pleted animals these cells must be attracted by other 
factors than activated complement components It is 
possible that the P M N s accumulate by Fc receptor 
mediated immune adherence to the deposited antibody 
T h e accumulation of P M N s in the capillary vessels in­
dependent of chemotactic complement components, re 
sembles that of a previously described model of acute 
antibody mediated rejection of rat skin xenografts in 
mice, in which the number of P M N s in the graft vessels 
after injection of high doses of antibody was enhanced 
rather than reduced by CoVF treatment (7) We have 
preliminary evidence that depletion of P M N s completely 
prevents the occurrence of albuminuria (unpublished 
data) 
We conclude that in this murine model of anti-GBM 
nephritis, the albuminuria, the influx of P M N s , and the 
subsequent intravascular coagulation and necrosis occur 
independently of complement fixation The prominent 
presence of P M N s in the glomeruli suggests that the 
renal injury in this model is caused by a complement 
independent, neutrophil dependent mechanism 
M E T H O D S 
ANIMALS 
BIO D2 new, BIO D2 old (congenitally C5 deficient) and 
С57ВІЛ0 mice, originally obtained from the Jackson Labora 
tory, Bar Harbor, Maine, were kept in our laboratory by con 
tinuous brother sister matings For all experiments, we used 
male mice at ages 3 to 4 months Randomly bred Swiss mice 
were purchased from the Central Institute for breeding of 
laboratory animals, TNO, Zeist, The Netherlands A goat, used 
for the preparation of the antiserum, was bought from a local 
breeder 
ANTI GBM SERLM 
A glomerular and tubular basement membrane suspension 
was prepared from Swiss mouse kidneys by a differential sie\e 
technique, followed by somcation and detergent treatment as 
previously described (3, 4) An antiserum against this prepa 
ration was raised in a goat The immunization procedure, the 
purification of the IgG traction of the antiserum, as well as the 
assessment of purity and specificity were carried out as de 
scribed before (3) In all experiments, a 5 0 ^ ammonium sulfate 
precipitate of the antisenim was used that contained 25 mg of 
IgG/ml, as measured by radial immunodiffusion (26) 
URINE AND BLOOD ANALYSIS 
Urinary albumin concentrations were determined by radial 
immunodiffusion, using a 50% ammonium sulfate precipitate 
of goat antiserum against albumin as described before (3Θ) 
Serum albumin concentrations were determined by the brom 
cresol green method (19) Serum urea and creatinine were 
measured in a CoBas Bio autoanalyser (Roche, Basel, Switzer 
land) The number of PMNs in blood, drawn from the retro 
bulbar plexus was calculated from leucocyte counts m a Coulter 
Counter (Coulter Electronics Ltd, Luton Beds, England) and 
differential counts in air dried May Grunwald Giemsa stained 
smears 
LIGHT MICROSCOPY 
Kidney fragments were fixed in Bourn's solution, dehydrated 
and embedded in paraplast (Amstelstad, Amsterdam, The 
Netherlands) and 4 μπι sections were stained with hematoxylin 
and eosin. Silver methenamine, and periodic acid Schiff The 
glomerular influx of PMNs was determined by counting of 
PMNs in at least 40 glomeruh/mouse in 3 mice/observation 
point, and expressed as the average number of PMNs/glomer 
ulus 
IMMUNOFLUORESCENCE 
Kidney fragments were snap frozen in liquid nitrogen, and 
2-дт cryostat sections were incubated with monospecific, flu 
orescein labeled goat anti mouse IgG (heavy and light chains), 
goat anti mouse C3 serum (both from Cappel Laboratories, 
West Chester Pennsylvania), rabbit anti goat Ig (Nordic, Til 
burg, The Netherlands) absorbed with 500 mg/ml of lyophihzed 
nonimmune mouse serum, and rabbit anti human fibrinogen, 
cross reacting with mouse fibrinogen (Dako, Copenhagen, Den 
mark) The sections were examined in a Leitz fluorescence 
microscope equipped with a Ploemopak epi illumination and 
the staining intensity was recorded semiquantitatively (grading 
0 to 4+) as earlier described (4) 
IMMUNOELECTRON MICROSCOPY 
The kidneys of a normal mouse were fixed by perfusion with 
a periodate lysine 2% paraformaldehyde as described earlier 
with minor modifications (4, 11), and blocks of cortex were 
immersed in the same fixative for an additional 4 hours Small 
pieces of tissue were placed in 50 т м NH4CI in phosphate 
buffered saline to quench aldehyde groups, and then cryopro 
tected by immersion in 10% dimethylsulfoxide in phosphate 
buffered saline for 1 hour, followed by freezing in isopentane 
cooled with liquid nitrogen Thick (30 μπι) frozen sections were 
incubated in 200 μ\ of the goat anti mouse GBM antibody 
diluted 1 250 or with normal goat Ig for 1Θ hours at 4 °C Bound 
goat Ig was detected by incubation with a peroxidase labeled 
rabbit anti goat Ig (Dakopatt) for 3 hours at room temperature 
The sections were cut on a LKB ultratome, and examined 
unstained in a Siemens Elmiskop 101 electron microscope 
STATISTICAL ANALYSIS 
For statistical analysis Wilcoxon's rank sum test was used 
Probability values <0 05 were regarded as significant All values 
are expressed as mean ± SD 
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ABSTRACT 
Anti-GBM nephritis in the mouse: the role of granulocytes in 
the heterologous phase. The role of polymorphonuclear 
granulocytes (PMNs) was studied in a murine model of anti-GBM 
nephritis in mice in which PMN depletion was induced by Total 
Body Irradiation of 7.5 Gy. In this model the development of 
albuminuria and glomerular lesions was previously shown to be 
independent of complement. Both in complement normal B10.D2 
new and in C5 deficient B10.D2 old mice PMN depletion comple-
tely prevented the albuminuria occurring after injection of 
low doses of anti-GBM serum, and severely depressed the 
albuminuria after injection of high doses. Glomerular deposi-
tion of antibody and C3 was similar to that in control mice. 
The glomerular influx of PMNs, characteristically present in 
both the complement normal and C5 deficient controls, was 
inhibited to 10%, or less, of control values. Fibrin deposi-
tion or necrosis did not occur. Injection of F(abl)2 frag-
ments of the anti-GBM antibody in non-irradiated mice also 
greatly diminished the glomerular PMN influx and reduced the 
albuminuria to physiological levels. We conclude that the 
albuminuria in this model is Fc-dependent and largely, if not 
completely, dependent on the influx of PMNs in the glomeruli. 
Among the many experimental models of anti-GBM nephritis this 
is the first one described in which the heterologous phase is 
complement-independent but PMN-dependent. 
46 
INTRODUCTION 
Insight in the pathogenesis of human glomerulonephritis has 
been greatly enhanced by studies in experimental models. 
Among these the model of anti-glomerular basement membrane 
(anti-GBM) nephritis, is one of the oldest and most extensi-
vely studied (1). In the classical model of anti-GBM nephri-
tis intravenous (i.v.) injection of heterologous antibody 
against the GBM induces glomerular damage, initiated by 
binding of the antibody to the GBM, followed by activation of 
complement, accumulation of polymorphonuclear granulocytes 
(PMNs), deposition of fibrin and necrosis of the glomerular 
capillaries. This early reaction of the so-called heterolo-
gous phase is accompanied by a dose-dependent proteinuria. 
After 5-7 days a second phase develops, caused by the binding 
of autologous antibodies to the heterologous immunoglobulins 
already deposited along the GBM. 
Especially the heterologous phase of anti-GBM nephritis, with 
its characteristic histological picture of an acute inflamma-
tory reaction, has been studied in several species and has 
provided an opportunity to test the influence of antibodies 
of different types and origin, and the role of inflammatory 
mediator systems in the development of the eventual glomeru-
lar damage. It has become clear that the pathogenic mecha-
nisms in this relatively simple model are complex and varia-
ble. The role of mediator systems, such as the complement 
system and PMNs, is dependent on animal species and on type, 
class and charge of the antibodies that are used (reviewed 
in 2) . The original hypothesis that the glomerular damage in 
anti-GBM nephritis is brought about by a sequence of events 
similar to that of the Arthus reaction (3), i.e. binding of 
antibody to antigen, activation of complement, attraction of 
PMNs and ultimate damage by lysozomal enzymes and oxygen 
radicals, seems not to be applicable to a number of models of 
glomerulonephritis in which either complement or PMNs were 
shown not to be essential mediators in the development of 
tissue damage (2) . On the other hand, in those models in 
which PMNs are essential, these cells are usually attracted 
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via complement activation. 
As reported earlier we have developed a classical model of 
anti-GBM nephritis in the mouse, with a reproducible dose-de­
pendent albuminuria, developing within 6 hr after injection 
of goat or rabbit anti-GBM serum, and characterized by signs 
of acute inflammation in the glomeruli with deposition of 
antibody, activation of complement, PMN influx, intravascular 
coagulation and necrosis (4). In contrast with this classical 
picture however, neither the albuminuria nor the histological 
lesions in the heterologous phase proved to be complement-de­
pendent (5) . 
The present study shows that in this complement-independent 
model PMNs are required for the development of the glomerular 
lesions. It is the first report of a PMN-dependent/comple-
ment-independent heterologous phase of anti-GBM nephritis. 
MATERIALS AND METHODS 
Animals. B10.D2 new and congenitally C5 deficient B10.D2 old 
mice, originally obtained from the Jackson Laboratory, Bar 
Harbor, Main, USA, were kept in our laboratory by continuous 
brother-sister matings. Only male mice were used, at ages of 
3 to 4 months. Randomly bred Swiss mice were purchased from 
the Central Institute for the breeding of laboratory animals, 
TNO, Zeist, The Netherlands. A goat, used for the preparation 
of the antiserum, was bought from a local breeder. 
Anti-GBM serum. A glomerular basement membrane (GBM) suspen­
sion was prepared from Swiss mouse kidneys as previously 
described (4,6). An antiserum against this basement membrane 
preparation was raised in a goat. The immunization procedure, 
the purification of the IgG fraction of the antiserum, as 
well as the assessment of purity and specificity were carried 
out as reported before (4). In all experiments a 50% ammonium 
sulphate precipitate of the antiserum was used that contained 
75 mg of IgG per ml, as measured in a radial immunodiffusion 
according to Mancini et al. (7). 
F(ab,)2 fragments of the mouse anti-GBM antibody were prepa­
red by digestion with pepsin as described by Nisonoff (8) . 
Briefly, the IgG preparation was dialysed for 4 hr at room 
temperature against 0.1 M sodium acetate buffer, pH 4.0. 
Pepsin was added at a ratio of 1 mg/100 mg IgG. Digestion was 
allowed to proceed at 37°С for 20 hr, and the precipitate was 
removed by centrifugation (10 min, 2000 g) . The supernatant 
was dialysed against phosphate-buffered saline, pH 7.4 for 4 
hr, concentrated, and fractionated by gel chromatography on a 
80x2 cm Ultrogel ACA-34 column (LKB products, Bromma, Sweden) 
with a separation range of 20-400 kD. Two major peaks with 
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extinction at 280 nm were collected. Polyacrylamide gel 
electrophoresis (PAGE) analysis showed that the first peak 
contained undigested IgG and F(ab,)2, and the second low 
molecular weight material. The material in the first peak was 
pooled, concentrated, and passed over an Ultrogel ACA-44 
column (separation range 10-130 kD) . Two elution peaks were 
observed and PAGE-analysis demonstrated that the second peak 
contained 95% pure F(abI)2 fragments, whereas the undigested 
IgG was present in the first peak. The material in the 
F(ab,)2 peak was pooled and concentrated to a final concen­
tration of 37 mg/ml, as measured in a Lowry assay (9). The 
molecular weights of F(abI)2 and undigested IgG could be 
correlated from the PAGE patterns by comparison with simulta­
neously applied marker proteins (Pharmacia, Uppsala, Sweden). 
We found that the F(ab,)2 fragments had approximately half 
the molecular weight of the undigested IgG molecules. Doses 
of the F(ab')2 fragments, expressed as mg of protein, could 
therefore be multiplied by a factor 2 to allow for a compar­
ison with doses of intact IgG on a molar basis. 
PMN-depletion. Mice were depleted of PMNs by Total Body 
Irradiation (TBI) consisting of a single dose of 7.5 Gy, at a 
dose rate of 2 Gy/min, with a 13 MeV electron beam, from a 
linear accelerator (CGR Saturne, Bue, France), 4 days before 
injection of the anti-GBM serum. After 24 hr of fasting the 
mice were anaesthetized by i.p. injection of sodium pentobar­
bital, 0.03 mg per g body weight (NarcovetR, Apharma B.V., 
Arnhem, The Netherlands) and placed between two perspex 
plates, the upper one being 1 cm thick. To prevent infection 
the mice were kept under aseptic conditions in a laminar flow 
unit from 1 day before irradiation till the end of the 
experiments, while they received Polymyxin В (40 mg/1) and 
Neomycin (100 mg/1) in their drinking water, as well as heat 
sterilized food. By day 4 after irradiation, i.e. at the time 
of injection of the antibody, many mice had lost up to 20% of 
their body weight, and showed a lowering of skin temperature, 
but otherwise the animals remained in excellent condition 
throughout the period of the experiments. 
Experimental protocol. At day 4 after TBI complement normal 
B10.D2 new mice and C5 deficient B10.D2 old mice were injec­
ted with 5.6 mg (low dose) or 22.5 mg (high dose) of goat 
anti-mouse GBM serum. The extent of glomerular protein 
leakage was determined in urine samples taken by bladder 
puncture at 2 hr and 6 hr after injection of the antibody, 
and in 18 hr samples of urine obtained by placing the animals 
in individual metabolic cages from 6-24 hr after injection. 
Since both irradiated and non-irradiated mice showed a 
tendency to dehydration and weight loss during this period 
all mice were injected with 1 ml 0.9% saline intraperitoneal-
ly immediately before putting them in the metabolic cages, 
wherein they only received water ad libitum. For determinati­
on of circulating leukocyte and platelet numbers, and concen­
trations of serum albumin, creatinine and urea, blood was 
drawn from the retrobulbar plexus at 2 hr, 6 hr, 24 hr, and 
at day 4 after administration of the antiserum. After blee­
ding, the kidneys were taken for histological examination. 
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The studies with the F(ab,)2 fragments of the anti-GBM serum 
were carried out only in the complement normal B10.D2 new 
mice. Of these animals urine samples were taken at 2 hr by 
bladder puncture and as 18 hr samples after placement of the 
mice in metabolic cages from 6-24 hr after injection of the 
F(ab,)2 serum. For histological examination kidneys were 
taken at 2 hr and 24 hr after injection. 
Laboratory and hematological examinations. Urinary albumin 
concentrations were determined by radial immunodiffusion, 
using a 50% ammonium sulphate precipitate of goat antiserum 
against albumin as described before (4). Serum albumin 
concentrations were determined by the bromcresol green method 
(10). Serum urea and creatinine were measured in a CoBas Bio 
autoanalyzer (Roch, Basel, Switserland) . Serum complement 
activity was measured in a sensitive hemolytic assay, based 
on the method described by Berden et al. (11), with modifica­
tions designed to make it applicable to smaller blood volumes 
and to increase the sensitivity (12) . Briefly, serum test 
samples of 40 μΐ were mixed with 25 μΐ 0.6% (v/v) SRBC 
suspension and 25 μΐ mouse anti-SRBC IgG. After an incubation 
period of 90 min at 37°C, unlysed cells were pelleted by 
centrifugation and the degree of hemolysis was determined in 
the supernatant by measurement of the extinction of 405 nm 
wave length. The hemolytic titer was expressed in hemolytic 
units per ml. One hemolytic unit was defined as the amount of 
serum capable of lysing 50% of the target SRBC. Using this 
assay we tested the effect of TBI on complement levels and 
confirmed the complement deficiency of the B10.D2 old mice. 
Leukocytes were counted in a Coulter Counter (Coulter Elec­
tronics Ltd, Luton Beds, England) and differential counts 
determined in air dried May-Griinwald-Giemsa stained smears. 
Platelets were counted in a Baker 820 platelet counter (Baker 
Instruments, Deventer, The Netherlands). 
Light microscopy. Kidney fragments were fixed in Bouin's 
solution, dehydrated and embedded in paraplast (Amstelstad, 
Amsterdam, The Netherlands) and 4 μιη sections were stained 
with hematoxylin and eosin. Periodic Acid Schiff and silver 
methenamine. The glomerular influx of PMNs was determined 
semi-quantitatively by counting of PMNs in at least 40 
glomeruli of three mice per observation point and expressed 
as the average number of PMNs per glomerulus. 
Immunofluorescence. Kidney fragments were snap frozen in 
liquid nitrogen, and 2 μπι cryostat sections were incubated 
with monospecific, fluorescein-labelled goat anti-mouse IgG 
(heavy and light chains) , goat anti-mouse C3 serum (both from 
Cappel Laboratories, West Chester, Pennsylvania, USA), rabbit 
anti-goat Ig (Nordic, Tilburg, The Netherlands) absorbed with 
500 mg/ml lyophylized non-immune mouse serum, and rabbit 
anti-human fibrinogen, crossreacting with mouse fibrinogen 
(Dako, Copenhagen, Denmark). The sections were examined in a 
Leitz fluorescence microscope equipped with a Ploemopak 
epi-illumination and the staining intensity was recorded 
semiquantitatively (grading 0 to 4+) as earlier described 
(6). 
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Statistical analysis. Significance of differences between the 
various groups was determined by the Wilcoxon test. P-values 
of less than 0.05 were considered significant. All values are 
expressed as mean ± SD. 
RESULTS 
PMN depletion by Total Body Irradiation. Our previous studies 
have shown that TBI is a reliable and relatively simple 
method to induce PMN depletion in mice, and has important 
advantages over other methods such as treatment with anti-PMN 
serum (13). The maximum effect of TBI on circulating PMNs is 
seen from day 3 after irradiation, and PMNs remain at very 
low levels for at least 7 days. Table 1 shows the numbers of 
PMNs, mononuclear leukocytes, and platelets in the peripheral 
blood in the B10.D2 new and B10.D2 old mice at day 4 after 
TBI of 7.5 Gy. The induced granulopenia in both strains was 
well below 100/μ1, which can be regarded as the upper limit 
of effective PMN depletion in mice, and persisted through day 
8 after irradiation, i.e. till the end of the experiments 
(data not shown). Parallel to the depletion of PMNs a similar 
decrease in numbers of mononuclear leukocytes was seen. The 
separate effects on lymphocytes and monocytes were not 
tested, because the differentiation between these cells, 
which is normally already difficult, was further impaired by 
moderate degrees of nuclear pycnosis due to the irradiation. 
Only a moderate decrease in platelet counts was found at day 
4 after irradiation, consistent with our earlier findings 
that the effect of TBI on platelet counts develops more 
slowly (13). TBI alone had no effect on the physiological 
albuminuria, that is seen in most murine strains. Pathologi­
cal albuminuria was defined as albuminuria of more than the 
mean physiological value plus two standard deviations, i.e. 
more than 55 мд/18 hr. TBI did not affect renal function as 
determined by serum creatinine and urea levels, and had no 
influence on the complement levels in the complement-normal 
B10.D2 new mouse strain (Table 1). 
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Table 1. Effects of Total Body Irradiation (7.5 Gy) in B10.D2 new and B10.D2 old mice3. 
PMNs/μΙ 
Mononuclear cells/μΐ 
Platelets χ 10-3/μ1 
Serum creatinine (дтоі/і) 
Serum urea (mmol/1) 
Serum albumin (g/l) 
Serum complement (U/ml) 
Albuminuria (Mg/18hr)c 
B10.D2 
Irradiated 
36±24* 
234±128* 
449±83* 
34±5 
8.0±1.7 
24±1 
102б±74 
60147 
(12)Ь 
: ( 9) 
(12) 
( 3) 
( 3) 
( 3) 
( 3) 
( б) 
new 
Controls 
1111+494 
7657±997 
858І156 
2917 
9.610.9 
2512 
1554+244 
31112 
(10) 
(10) 
(10) 
( 9) 
( 3) 
( 9) 
( 6) 
(60) 
Irradiated 
36±4* 
200164* 
579+208* 
3014 
7.711.1 
2811 
ND 
ND 
BIO. 
(7) 
(7) 
(7) 
(3) 
(3) 
(3) 
.02 old 
Controls 
838+383 
8023+1807 
762179 
2915 
9.111.2 
2512 
10 
21110 
(10) 
(10) 
(10) 
( 4) 
( 4) 
( 4) 
(60) 
a. All values, if not stated otherwise, determined at day 4 after irradiation. 
b. Number of mice tested in parentheses. 
с Albuminuria at day 5 after irradiation. 
* Significant difference between irradiated and control animals (p<0.05). 
Albuminuria(Mg/18hr) 
10,000-
8000-
6000-
¿000-
2000-
Bio D2new Bio Dzold Bio D2n«v Вю D2old 
ι 1 ι I 
Dose of 
GaM-GBM 5 6mg 22 5mg 
Figure 1: The influence of PMN depletion on the albuminuria 
in B10.D2 new and C5 deficient B10.D2 old mice, 
measured from 6-24 hr after injection of 5.6 mg 
or 22.5 mg goat anti-mouse GBM serum. Mice were 
depleted of PMNs by Total Body Irradiation (7.5 
Gy) at day -4. The upper limit of physiological 
albuminuria, calculated as the mean albuminuria 
plus two standard deviations, in untreated mice 
is 55 мд/18 hr. 
The influence of PMN depletion on the effect of injection of 
anti-GBM serum in complement-normal and C5 deficient mice. 
Figure 1 shows the effect of PMN depletion on the albuminuria 
in 18 hr samples of urine, collected 6-24 hr after injection 
of goat anti-mouse GBM serum in complement normal B10.D2 new 
and C5 deficient B10.D2 old mice. After injection of a low 
dose (5.6 mg), the albuminuria in irradiated animals remained 
at levels below (B10.D2 new mice) or just above (B10.D2 old 
mice) physiological values, being 38 ±26 (n = 22) and 70 ± 
41 мд/18 hr (n = 11), respectively. Also after injection of a 
high dose of antibody (22.5 mg) the albuminuria was markedly 
reduced to 176 ± 154 дд (η = 18) in B10.D2 new and 378 ± 348 
fig (n = 11) in B10.D2 old mice, as compared to the albuminu-
I I Control 
[ ] ] Irradiated 
^ physiologic 
albuminuria 
гЧ^ унтера 
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Table 2. Histological and immunohistological findings in glomeruli of irradiated (TBI 7.5 Gy) and non-
irradiated B10.D2 new mice after injection of goat anti-mouse GBM antiserum3. 
Dose of Time 
GaM-GBM after 
serum injection 
(mg) (hr) 
Number of PMNs 
per glomerulus'3 
Deposits in capillary wall 
(mean va 
Irradiated 
0.0 
0.3 
0.1 
0.0 
0.0 
0.3 
0.2 
0.0 
ilues) 
Controls 
0.1 
3.5 
ND 
0.2 
0.1 
4.3 
ND 
0.1 
Goat IgGc 
Irradiated 
_ 
++++ 
++++ 
++++ 
_ 
++++ 
++++ 
++++ 
Control! 
_ 
++++ 
++++ 
++++ 
_ 
++++ 
ND 
++++ 
Mouse C3C Fibrin 
Controls Irradiated Controls 
5.6 
22.5 
0 
2 
б 
24 
0 
2 
б 
24 
++ 
+ 
+ 
++ 
++ 
+ 
++ 
ND 
+ 
++ 
ND 
+ 
ND 
++ 
+ 
ND 
+++ 
a. Comparable results were obtained in B10.D2 old mice. 
b. Counted in 40 glomeruli per mouse in at least 3 mice per observation point. 
c. Linear staining with anti-goat IgG. 
d. Fine granular staining with anti-mouse C3 in the capillary walls. 
ria in control mice of the same strains (10,484 ± 5460 ßg (η 
= 27) and 4127 ± 1909 ßg (η = 18)). At 4 days after injection 
of the antibody the albuminuria in irradiated B10.D2 new mice 
was 28 ± 7 Mg/18 hr after injection of the low dose (n = 6) 
and 84 ± 37 дд/18 hr after injection of the high dose (n = 
4), showing that albuminuria also remained low at later 
stages. 
Injection of goat anti-GBM serum causes both in B10.D2 new 
and B10.D2 old mice easily glomerular lesions, histologically 
characterized by accumulation of PMNs in the capillary 
vessels followed by fibrin deposition and necrosis (Figure 
2) . Immunohistologically an immediate, linear deposition of 
the injected antibody along the GBM and a transient localiza­
tion of C3 can be seen, preceding the deposition of fibrin 
thrombi. In the irradiated groups the binding of the antibody 
to the GBM was unimpaired but no PMN accumulation was seen, 
no inflammatory lesions nor necrosis did occur, and no fibrin 
deposition could be found (Table 2, Figure 3). No differences 
were seen between the histological lesions of B10.D2 new and 
the 05 deficient B10.D2 old mice. 
Figure 2: Influx of PMNs in glomeruli at 2 hr after injec­
tion of 22.5 mg goat anti-mouse GBM in PMN 
depleted B10.D2 new mice (A) and non-irradiated 
controls (B). (PAS, x800). 
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Figure 3: Immunofluorescence findings after injection of 
22.5 mg of goat anti-mouse GBM antibody in PMN 
depleted B10.D2 new mice. A: Linear binding of 
goat immunoglobulins to the capillary wall. B: 
Deposition of mouse C3 along the capillary wall 
in a fine granular or homogeneous pattern at 2 hr 
after injection of GaM-GBM. C: Absence of fibrin 
deposits in the glomeruli at 24 hr after injecti-
on of GaM-GBM serum. D: Focal and segmental 
deposits of fibrin at 24 hr after injection in 
non-irradiated controles (x640). 
56 
Table 3. Albuminuria and glomerular lesions in B10.D2 new mice after injection of FCab'^ 
fragments of goat anti-mouse GBM serum (GaM-GBM). 
Injected 
antiserum 
Dose No. Albuminuria 
in of in 
mg animals Mg/18 hra 
PMNs 
per 
glomerulus13 
Deposits in 
capillary wall 
Goat IgGc 
++ 
+++ 
++++ 
++++ 
++++ 
++++ 
Mouse C3' 
_ 
-
-
-
+ 
++ 
F(ab')2 
GaM-
GBM6 
Undigested 
GaM-GBM 
Non-immune 
Goat-IgG 
None 
0.4 
1.6 
6.2 
11.2 
5.6 
22.5 
5.6 
3 
3 
3 
3 
19 
27 
5 
30 
80±54 
64±22 
70±20 
70±10 
1248±453 
10,484±5460 
89±61 
31±12 
1.0 
1.1 
0.6 
0.7 
3.9 
5.0 
0.4 
0.1 
a. Albuminuria measured in urine collected from 6-24 hr after injection of the antiserum. 
b. Mean values in 40 glomeruli of 3 mice per observation point at 2 hr after injection of 
the antiserum. 
c. Linear staining with anti-goat Ig.G at 2 hr after i.v. injection. 
d. Fine granular staining with anti-mouse C3 in the capillary walls at 2 hr after i.v. 
injection. 
e. The approximate equivalent dose of undigested antiserum can be calculated by multiplying 
the dose of the F(ab,)2 fragments by a factor 2 (see text). 
In a p r e v i o u s s t udy we found t h a t i n t h i s model of anti-GBM 
n e p h r i t i s complement a c t i v a t i o n does n o t p l a y an e s s e n t i a l 
r o l e , s i n c e i t s d e p l e t i o n by t r e a t m e n t w i t h Cobra Venom 
F a c t o r had no e f f e c t on e i t h e r t h e a l b u m i n u r i a , t h e PMN 
i n f l u x o r t h e o t h e r h i s t o l o g i c a l l e s i o n s i n B10.D2 new or 
B10.D2 o ld mice ( 5 ) . I t seemed t h e r e f o r e t h a t i n t h i s murine 
model t h e PMNs, t h a t a r e p r e s e n t in l a r g e numbers i n t h e 
g l o m e r u l i a t 2 h r a f t e r i n j e c t i o n of t h e a n t i b o d y , a r e not 
a t t r a c t e d t o t h e GBM by a c t i v a t e d complement, b u t p r o b a b l y 
adhe re by b i n d i n g of t h e i r Fc r e c e p t o r s t o t h e d e p o s i t e d 
h e t e r o l o g o u s a n t i b o d y . To t e s t t h i s a s sumpt ion we i n j e c t e d 
F ( a b , ) 2 f ragments of t h e goa t an t i -mouse GBM serum i n doses 
t h a t were comparable t o doses of t h e u n d i g e s t e d a n t i b o d y . 
Tab le 3 shows t h a t i n j e c t i o n of F ( a b l ) 2 f ragments of t h e 
a n t i s e r u m caused an a lbuminu r i a t h a t was only s l i g h t l y above 
t h e p h y s i o l o g i c a l l e v e l , and t h a t a l s o t h e PMN accumula t ion 
i n t h e g l o m e r u l i was markedly reduced i n comparison t o t h a t 
a f t e r i n j e c t i o n of u n d i g e s t e d a n t i s e r u m . In immunofluo-
r e s c e n c e w i t h a n t i - g o a t IgG t h e b i n d i n g of t h e F ( a b , ) 2 
a n t i b o d y t o t h e GBM was s i m i l a r t o t h a t of u n d i g e s t e d a n t i b o -
dy . In t h e s e mice we saw no d e p o s i t i o n of C3, a t 2 h r i n con-
Table 4. Comparison of effects of TBI and local renal i r radiat ion 
(7.5 Gy) in B10.D2 new mice. 
Irradiation 
Total body 
Renal region 
Nene 
GaM-GBT1 
(22.5 mg) 
+ 
+ 
+ 
Circulating 
IMNs per Mlb 
(mean ± SD) 
36±24 (12)e 
24±16 ( 3) 
174±100 ( 6) 
4491252 ( 3) 
1111±495 (10) 
ND 
EWNs per 
glcgnerulusc 
0.0 (3) 
0.3 (3) 
0.1 (3) 
4.4 (2) 
0.1 (6) 
4.3 (3) 
Albuminuria 
(Mg/18 hr)d 
60+47 ( 6) 
1761154 (18) 
62146 ( 9) 
715311678 ( 9) 
31112 (30) 
502412121 ( 6) 
a. Intravenous injection a t day 4 af ter i r radia t ion. 
b . IMNs were counted a t day 4 after i rradiat ion, and, i f antibody was 
injected a t 2 hr after i.V. injection. 
c . Mean values in 40 glcmeruli per mouse a t 2 hr af ter injection of 
antibody. 
d. Albuminuria measured in urine collected from 6-24 hr af ter injec-
t ion of antibody. 
e. Number of mice tested in parentheses. 
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trast to the maximal staining at 2 hr in the groups that 
received the undigested antiserum. However, at 24 hr after 
injection C3 deposits were also present in the Ffab1)2-trea-
ted group. Histologically, the glomeruli of the mice that 
received the F(abI)2 fragments did not show necrosis or 
deposition of fibrin. 
To exclude the possibility that the considerable decreases in 
albuminuria in PMN depleted mice were caused by a local 
effect of the TBI on the capillary walls, we tested the 
effect of injection of antibody in BIO.02 new mice that were 
irradiated with 7.5 Gy only on the renal region. For determi­
nation of the radiation field we performed intravenous pyelo­
graphy in 14 mice and from these findings defined the renal 
region as the part of the body from the processus xyphoideus 
to 2 cm caudal from that point. At day 4 the mice were 
injected with anti-GBM antibody and were placed 6 hr thereaf­
ter in metabolic cages for 18 hr, similar to the other 
experimental groups. Renal tissue was taken for histology at 
0,2, and 24 hr after injection of antibody. The results are 
given in Table 4. Renal irradiation alone did induce neutro­
penia at day 4 (174 ± 100 per μΐ, η = 6), but when these mice 
were injected with anti-GBM serum the number of circulating 
PMNs quickly increased to values of 449 ± 252 and 600 + 131 
per μΐ at 2 hr and 24 hr respectively. The glomerular influx 
of PMNs at 2 hr was similar to that in mice with normal PMN 
counts. Renal irradiation alone did not induce albuminuria, 
while injection of anti-GBM serum caused an increase compara­
ble to that in non-irradiated mice. 
Injection of anti-GBM serum did not significantly affect 
renal function in irradiated mice or in controls, since from 
2 hr-4 days after injection (data not shown) serum levels of 
creatinine, urea and albumin remained in the same ranges as 
those given in Table 1. Although we found earlier that 
complement does not play a substantial role in this model we 
also tested the CH50 titers of complement in BIO.02 new mice 
during the period of the experiment, and found no significant 
differences from the levels in untreated and non-irradiated 
controls. 
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DISCUSSION 
Our results show that TBI with resulting PMN depletion 
greatly or totally prevents both the albuminuria and the 
histological lesions that in control mice immediately follow 
the injection of goat anti-GBM serum. That this effect is not 
the result of the reaction of the renal tissue itself to the 
TBI is illustrated by the unchanged high albuminuria in mice 
that received similar antibody treatment with irradiation on 
the kidneys only. Our data strongly suggest that the damage 
to the glomerular vessels, leading to the protein leakage and 
tissue destruction induced by i.v. injection of anti-GBM 
antibody, is effected in this model by the PMNs, that accumu-
late in the glomeruli and are present in large numbers at 2 
hr after injection of the antibody. From our previous obser-
vations that Cobra Venom Factor treatment did not alter the 
reaction, and that C5 deficient B10.D2 old mice showed 
reactions that are not essentially different from those in 
the complement normal congenie strain, we concluded that the 
PMNs are not attracted to the glomerular vessels by chemoat-
tractant complement factors, but that the granulocytes 
probably bind to the deposited anti-GBM antibody by their Fc 
receptors. The finding that injection of F(ab,)2 fragments of 
the antibody induced considerably less PMN accumulation is 
consistent with this hypothesis. In these mice we also saw 
that injection of the F(ab,)2 fragments of the antibody did 
not result in albuminuria and glomerular tissue destruction 
such as occurs after injection of equivalent molar doses of 
the non-digested antibody. 
Among the many experimental models of anti-GBM nephritis this 
is the first one that is complement independent, but PMN 
dependent in its heterologous phase. Only the group of Naish 
et al. reported PMN dependent/complement independent inducti-
on of glomerular damage in anti-GBM nephritis, but their data 
do not refer to the heterologous phase, but to an accelerated 
autologous phase in a model of sheep anti-GBM nephritis in 
rabbits (14,15,16). In all other PMN dependent models of the 
heterologous phase the granulocyte accumulation seems to be a 
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consequence of complement activation. Decomplementation 
before the administration of the anti-GBM antibodies in rats 
and rabbits inhibits the proteinuria and the infiltration of 
PMNs (2,17,18). While no other examples of a complement 
independent/PMN dependent mechanism can be found in experi-
mental glomerulonephritis, there is evidence that it can 
occur in other situations. We have found previously that in a 
model of acute antibody-mediated skin graft rejection, the 
accumulation of PMNs at the graft site after injection of 
specific antibody is also not diminished by complement 
depletion (19). 
Our conclusion, that complement plays no essential role in 
the initial damage, is in apparent contradiction with the 
immunohistological findings as summarized in Table 2 and 3, 
where deposition of C3 can be demonstrated between 2 and 24 
hr after injection of the antibody. However, in our preceding 
study with CoVF treated mice, C3 was not demonstrable in the 
serum and IF with anti-C3 serum was negative at all times, 
while the albuminuria and glomerular lesions were identical 
to those in the control groups. This leads to the conclusion 
that complement fixation is not essential for the pathologic 
reaction to occur. In the groups that received F(ab')2 
fragments of the antiserum the appearance of C3 was retarded, 
being negative at 2 hr (Table 3) and prominent at 24 hr (data 
not shown). Generally F(ab,)2 fragments are not expected to 
induce complement activation along the classical pathway, but 
activation of the alternative pathway by F(abl)2 fragments 
can occur (20,21). This activation may develop more slowly 
which could explain the maximal activity found at 24 hr. 
Still, also this type of complement activation cannot be 
considered an important factor in the pathogenesis of the 
glomerular lesions, since both the PMN accumulation and the 
albuminuria were markedly reduced when compared to that in 
controls that received similar amounts of undigested antise-
rum. 
Theoretically it remains possible that not only PMNs, but 
also mononuclear cells play an important role in the immuno-
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logically induced reaction. Although some reports have 
described a mixed mononuclear and neutrophil infiltrate in 
the first hours of the heterologous phase of anti-GBM nephri-
tis, it is generally believed that monocytes or lymphocytes 
do not effect glomerular injury in the early phase (1,2). 
There is only a single report suggesting that in a rabbit 
anti-rat GBM nephritis, lymphocytes are possible mediators of 
the damage at this stage (22) . A definite role for the 
monocyte in mediating capillary wall damage has only been 
documented for the autologous phase of anti-GBM nephritis 
(23-26). We determined the composition of the cellular influx 
in the capillary loops only in routinely stained histological 
sections, and not by more advanced histological techniques. A 
role for mononuclear leukocytes, however, seems not likely. 
Morphologically we observed no or practically no mononuclear 
cells in the capillary vessels, and even if they were present 
they were by far outnumbered by the PMNs, especially in the 
initial hours after the administration of the anti-GBM 
antibodies, when the enhanced permeability of the capillary 
wall was first seen. 
Since the glomerular damage caused by the injection of the 
antiserum is accompanied by platelet aggregation, thrombosis 
and fibrin deposition, we also have to consider a mediating 
role by platelets and the coagulation system, which could 
have been affected by TBI. However, a primary role for 
platelets seems even more unlikely than for mononuclear 
cells, since the number of platelets was only moderately 
decreased at day 4 after TBI, and the remaining 60-70% can be 
considered sufficient to cause thrombosis when effectively 
triggered. Indeed, we found in the previously mentioned model 
of acute antibody-mediated rejection of skin grafts in the 
mouse, that a similar course of TBI, did not impair platelet 
function as evidenced by uninhibited platelet aggregation and 
coagulation after injection of specific antibody (27). 
Whether platelets or coagulation system become involved 
secondarily to the PMN dependent induction of the inflammato-
ry reaction remains to be studied. 
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It would be elegant to corroborate our findings by more 
specific elimination and reconstitution of PMNs, thus circum-
venting the effect of TBI on mononuclear cells and platelets 
and possible other effector systems (18,28). An attractive 
approach would be to induce a highly specific PMN depletion 
without effects on other cells by using a specific anti-PMN 
serum. In a former study we have found, however, that it is 
very difficult to prepare relatively pure suspensions of 
murine PMNs, necessary for immunization (13). Experimentally 
induced peritoneal exsudâtes contain 10 to 30% mononuclear 
cells, and separation of the granulocytes on the basis of 
selective sedimentation is not possible in this species. 
Anti-mouse PMN serum prepared in this way is only moderately 
effective while treatment with the antiserum severely under-
mines the general condition of the animals. The difficulty in 
preparing pure suspensions of physiologically unaltered PMNs 
makes it also impossible to perform reconstitution experi-
ments in PMN depleted mice. 
When we conclude that in our model PMNs are essential effec-
tor cells in the induction of the glomerular injury we have 
to assume that the initial damage is caused by the reaction 
products of these cells. It is believed that immune adherence 
of PMNs via their Fc receptors to the planted heterologous 
antibody on the glomerular capillary wall, activates these 
cells and stimulates the release of hydrolytic enzymes 
(1,2,17,18,29,30) and the generation of oxygen radicals 
(31,32) with consequent digestion of the GBM (33,34). The 
finding that blocking or inactivation of reactive oxygen 
metabolites by administration of catalase or desferrioxamine 
inhibit the proteinuria in anti-GBM nephritis in rats, can 
support this assumption (31,32). Whether this mechanism for 
GBM degradation is also relevant to the form of neutrop-
hil-dependent glomerulonephritis described here has to be 
explored. 
It appears from the literature on the heterologous phase of 
anti-GBM nephritis that glomerular damage can be brought 
about along several pathways. The injury can be induced by 
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the deposited antibody itself, by activated complement 
components, or by the complement-mediated attraction of PMNs 
(1,2). There is evidence that the quantity of antibody bound 
is important in determining which of the abovementioned 
mediator systems will prevail (35,36). The complement inde-
pendent/PMN dependent pathogenesis of glomerular damage in 
our murine model adds a new pathway of mediation to this 
already multivariable spectrum. In fact the existence of such 
a pathway has already been assumed by others (2) . Our model 
will enable further studies of complement independent induc-
tion of tissue damage by PMNs and may thereby give new 
insight in the role that these cells play in immunological-
ly-induced glomerulonephritis. 
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A N T I G L O M E R U L A R B A S E M E N T M E M B R A N E N E P H R I T I S 
I N B E I G E M I C E 
Deficiency of Leukocytic N e u t r a l Prote inases Prevents the I n d u c t i o n 
of A l b u m i n u r i a in the H e t e r o l o g o u s Phase 
BY GIDEON SCHRIJVER, JOOST SCHALKWIJK,* JOHANNA С M ROBBEN,! 
KARELJ M ASSMANN.t AND ROBERT A Ρ KOKNE 
From the Department of Internal Medicine, Divisions of Nephrology and *'Rheumaloloqy, and the 
^Department oj Pathology, University Hospital Nijmegen, Nijmegen, ¡he Netherlands 
The glomerular damage during the early phase of the passive antiglomerular base-
ment membrane (GBM) ' nephritis, a well-known model of experimental renal dis-
ease, is dependent on complement and polymorphonuclear granulocytes (PMN) in 
most animal species studied (1-3). Recently wc have described a murine model of 
anti-GBM nephritis, in which the massive albuminuria occurring after the injection 
of heterologous antibody is not mediated by complement, but is completely depen-
dent on the presence of P M N in the glomeruli (4). Lysosomal proteinases and reac-
tive oxygen metabolites (ROM) from activated PMN, acting cither alone or syner-
gistically, have been implicated as agents contributing to the glonrerular injury and 
enhanced permeability for proteins (5-12) Activated P M N secrete lysosomal en-
zymes, especially when they are firmly attached to extracellular matrices (8-10, 13, 
14). It has been established that neutral proteinases are major factors in tissue de-
struction at sites of inflammation. These enzymes can cleave many if not all of the 
constituents of the extracellular matrix, including the GBM (13-17). Not only lysosomal 
proteinases but also ROM, generated during a respiratory burst from activated PMN, 
can function as mediators of tissue injury (16, 18, 19). Several in vitro and in vivo 
studies have reported the participation of R O M in ncutrophil-depcndent glomer-
ular disease (6, 7, 11, 12, 17). R O M have been shown to degrade GBM in vitro in 
concert with lysosomal proteinases, although others could not confirm this syner-
gistic effect (20-22). In most experiments the evidence of their mediator function 
of glomerular injury is largely derived from the inhibitory elfects of R O M scavengers 
on the damage produced by P M N (5-7, 17, 23). 
To examine more precisely the role of leukocytic neutral proteinases, we induced 
an anti-GBM nephritis in C57BL/6J,bg/bg (beige) mice with a genetic defect analo-
gous to the Chédiak-Higashi syndrome in man, in which P M N are reported to be 
deficient for elastase and cathepsin G (24, 25). The severe albuminuria after injec-
This work was supported by a grant from the Dutth Kidney Foundation Address correspondente to 
Gideon Schrijver, Μ Π , Dept of Internal Medicine, Div of Nephrology, University Hospital Nijmegen, 
Ρ Ο Box 9101, 6500 HB Nijmegen, The Netherlands 
' Abbreviations usedin this paper DFO, dcsfcrnoxaminc, GBM, glomerular basement membrane, PMN, 
polymorphonuclear leukocyte, RaM-GBM, rabbit anti-mouse GBM antibody, ROM, reattive oxygen 
metabolites 
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t ions of a n t i - G B M an t ibod ie s in n o r m a l con t ro l mice , d id not occur in this par t ic -
u la r beige m o u s e s t ra in , despi te the p resence of a c o m p a r a b l e influx of P M N in 
the g lomeru l i S ince the in v i t ro supe rox ide p r o d u c t i o n of P M N from beige mice 
was n o r m a l , it is c o n c l u d e d tha t leukocytic neu t r a l p ro te inases a r e respons ib le for 
the G B M d a m a g e tha t leads to a l b u m i n u r i a in th is mode l F u r t h e r m o r e , results of 
inh ib i to ry s tudies wi th R O M scavengers in a n t i - G B M nephr i t i s i n d u c e d in BIO D 2 
new mice suggest t ha t R O M do not pa r t i c ipa te in the i n d u c t i o n of the a l b u m i n u r i a 
in this mode l 
M a t e r i a l s a n d M e t h o d s 
Reaçents The following materials were obtained from the indicated sources catalasc (Sigma 
Chemical Co , St Louis, M O ) , PMSF, cemmide, and P M A (Sigma Chemical Co ), desfern-
oxamine mesylate (DFO) (Ciba-Gcigy, Basel, Switzerland), methoxysuccinyl-alanyl-alanyl-
propyl valyl aminomcthylcoumann (Bachern, Bubendorf, Switzerland), FITC (BDH, Poole, 
UK), FITC-labeled swine anti-rabbit Ig, and FITC-labeled rabbit an t i -human fibrinogen 
(Dako Corp , Copenhagen, Denmark), FITC-labeled goat ant i -mouse IgG (heavy and light 
chains), and FITC-labeled goat ant i -mouse C3 (Cappel Laboratories, West Chester, PA), 
glutaraldehyde (LADD, Burlington, VT) , sodium cacodylatc and lead citrate (BDH Chem-
icals Ltd ), osmium tetroxide (OsO,)) (Johnson Matthey Chemicals Ltd , Roystone, UK) , 
IFA (Difco Laboratories, Detroit, MI) , hematoxylin, eosin, Epon 812, and uranyl acetate 
(Merck, Darmstadt, FRG), paraplast (Amstelstad, Amsterdam, The Netherlands), Sepharose 
4B-coupled protein-Α (Pharmacia, Uppsala, Sweden), XM-50 diaflow membrane (Amicon 
Corp , Scientific System Division, Lexington, MA), Dulbecco's PBS (Flow Laboratories, Ir­
vine, Scotland) 
Animals C57BL/6J,bg/bg (beige), C57BL/6J, + /+ (control) and BIO D2 new mice were 
originally obtained from T h e Jackson Laboratory (Bar Harbor, M E ) Only male mice were 
used at ages of 3-4 mo Randomly bred Swiss mice were purchased from the Central Institute 
for the Breeding of Laboratory Animals, T N O , Zeist, T h e Netherlands Rabbits, used for 
the preparation of the antiserum, were bought from a local breeder 
Production of Anti-mouse GBM Antibodies G B M was prepared from Swiss mouse kidneys 
bv a differential sieve technique, followed by somcation and detergent treatment as previ­
ously described (26, 27) Antisera against this basement membrane suspension were raised 
in rabbits T h e pooled antiscra were heated at 5 6 0 C for 45 m m and the IgG fractions were 
purified by affinity chromatography on a Sepharose 4B-coupled protein-Α column T h e IgG 
antibodies were concentrated by ultrafiltration with an XM-50 Diaflow membrane, sterilized 
by passage through a sterile 0 2-/im filter and stored at - 3 0 o C T h e IgG concentration was 
measured by the radial immunodiffusion technique (28) 
Induction of Anh-GBMNephritis Anti-GBM nephritis in the mouse was induced by intra­
venous injection of rabbit anti-mouse G B M ( R a M - G B M ) antibodies, as described previ­
ously (4, 26) A dosc-rcsponsc study was performed in C57BL/6J,bg/bg (beige) and 
C57BL/6J, + /+ (control) mice that received increasing amounts (1 4-22 mg) of R a M - G B M 
antibodies Albuminuria, as a sign of glomerular protein leakage, was measured in 18-h urine 
samples collected 1 d before, and between 6 and 24 h after the injection of the R a M - G B M 
antiserum During their confinement in individual metabolic cages the mice received only 
tap water ad lib Pathological albuminuria was defined as a value greater than the normal 
mean plus two standard deviations Urinary albumin concentrations were measured by radial 
immunodiffusion in 18-h urine samples, using a goat antiserum against mouse albumin (27) 
T h e kidneys of four mice, killed at 2 and 24 h after injection of 2 8 and 11 mg of the anti-
G B M serum, were processed for histological examinations 
Isolation of Peritoneal PMN Mouse peritoneal cells were elicited by injection of 0 5 ml ι ρ 
of IFA in beige and control mice After 24 h the cells were harvested by lavaging the perito­
neal cavity with ice-cold saline T h e cell suspension, containing >90% of P M N , was washed 
twice in saline and resuspended in Dulbecco's PBS when used for the determination of su­
peroxide production For the measurement of the elastase activity, the cells were disrupted 
72 
SCHRIJVER ET AL 
by sonication in 0 5 M NaCl, 0 4% cetrimide, 0 1 M Tris, pH 8 0, as described before ( P M N 
extract) (29) 
Superoxide Production and Elastase Activity from Isolated PMN T h e superoxide production by 
peritoneal P M N s (lOVml) was determined upon stimulation with 100 ng/ml P M A in Dul-
becco's PBS at 3 7 0 C for 15 m m Superoxide dismutase mhibitable cytochrome с reduction 
was measured as described before (30), assuming an extinction coefficient of 21,000/M/cm 
(difference between reduced and oxidized form) T h e rate of superoxide production is ex­
pressed as nmol cytochrome с reduced per minute per 10'' cells To confirm the reported 
deficiency of leukocytic neutral proteinases, we measured the elastase activity Irom the iso­
lated peritoneal P M N fluorimctncally using methoxysuccinyl alanyl alanyl prolyl valyl-
ammomethylcoumarme as a substrate (31) T h e enzyme content of the P M N is expressed 
as pkatal per IO6 cells, 1 pkatal being the amount of enzyme that converts 1 pmol of sub­
strate per second under the given assay conditions 
Degradation of GBM by PMN Extracts G B M from mouse kidneys (2 mg/ml) was labeled 
with 0 5 mg/ml F I T C for 6 h at 17°C, yielding a preparation of M 6 /ig F I T C per milligram 
G B M Breakdown o f G B M - F I T C was measured as follows 50 μΐ o f G B M Η I С (2 mg/ml) 
suspended in phosphate buffci (pH 7 4) was added to 50 μ\ of a P M N extract (10' cells/ml, 
pool of five mice) T h e mixture was incubated at 3 7 0 C for 60 mm, 1 ml phosphate buflcr 
was added, and after ccntnfugation (5 mm, 10,000 g) the amount of solubihzed G B M in 
the supernatant was measured fluorimctncally at 488 nm (excitation) and 520 nm (emis 
sion) Maximum fluorescence was determined by exhaustive trypsmisation of the G B M - F I T C 
preparation Degradation of G B M by P M N extracts was expressed as a percentage of the 
total fluorescence PMSF, a serine proteinase inhibitor, was added at 1 m M to the P M N 
extracts for 60 mm, before the incubation with G B M - F I T C 
Effect of Catalase and Desferrwxamine on Albuminuria in BIO D2 New Mice 1 hymol free bo­
vine catalase, which converts Н^Ог to Oi and НгО, was obtained in a crystalline form con-
taming 11,000 U/mg 10 mg of catalase was injected intravenously together with 5 3 mg of 
antibodies in BIO D2 new mice T h e iron chelator dcsfcrnoxaminc mesylate was dissolved 
in distilled water at a final concentration of 75 mg/ml BIO D2 new mice received 7 5 mg 
s с and 2 5 mg ι ν of D F O before the administration of 5 3 mg of antibodies Albuminuria 
was measured as described before Morpholical studies were done on kidneys of mice killed 
2 h after the administration of antibody 
Light Microscopy, Immunofluorescence, and Electron Microscopy Kidney fragments were fixed 
in Bourn's solution, dehydrated, and embedded in paraplast (Amstelstad, Amsterdam, T h e 
Netherlands) and 4-μιη sections were stained with hematoxylin and cosin, Periodic Schiff 
and Silver methenamine, as mentioned earlier (27) T h e glomerular influx of P M N s was 
determined by counting of P M N s in at least 40 glomeruli per mouse in four mice per obser­
vation point, and expressed as the average number of P M N per glomerulus For im­
munofluorescence, kidney fragments were snap frozen in liquid nitrogen, and 2-/im cryostat 
sections were stained with FITC-labcled swine anti-rabbit IgG, goat anti-mouse IgG (heavy 
and light chains), and C 3 , and rabbit ant i-human fibrinogen, which crossreacts with mouse 
fibrinogen T h e sections were examined in a Leitz fluorescence microscope equipped with 
a Ploemopak epnllumination and the staining intensity was recorded semiquantitatively (on 
a scale from 0 to 4 + ) as described before (27) For electron microscopy small pieces of cortex 
were fixed in 2 5% glutaraldehyde dissolved in 0 1 M sodium cacodylate buffer, p H 7 2, for 
4 h at 4 0 C , and washed in the same buflcr T h e tissue fragments were posthxed in phosphate-
buffered 2% OSO4 for 2 h, dehydrated, and embedded in Epon 812 Ultrathin sections were 
cut in an ultratome ( L K P Produkter, Bromma, Sweden) and stained with 5% uranyl acetate 
for 45 m m and with lead citrate for 2 m m at room temperature T h e sections were examined 
in an electron microscope ( E L M I S K O P 101, Siemens, Berlin, FRG) 
Statistical Analysis For statistical analysis, Wilcoxon's rank sum test was used p values 
<0 05 were regarded as significant All values are expressed as means ± SD 
Results 
Albuminuria P r e v i o u s s tudies have shown t h a t t h e ear ly p h a s e of a n t i - G B M 
n e p h r i t i s in C57BL/10, BIO D 2 new, a n d BIO D 2 old m i c e is c h a r a c t e r i z e d by a dose-
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T A B L E I 
Albuminuria in C57BL/6J,bg/bg and C57BL/6J, +/+ Mice 
at Day I after the Intravenous Injection of RaM-GBM 
Dose 
mg 
1 1 
2 a 
5.5 
11 
22 
None 
of RaM GBM 
Albuminuria 
C57BL/6J,bg/bg 
61 ± 26 (5)* 
78 ± 41 (5)t 
6 4 + 1 5 (5)« 
144 ± 95 (6)» 
434 ± 4 1 4 ( 6 ) » 
112 ± 90 (24)t 
Mg/J8 h 
C57BL/6J, + / + 
63 ± 23 (5) 
344 + 87 (6) 
1,634 ± 713 (6) 
4,747 + 1,548 (6) 
7,913 ± 3,989 (6) 
51 ± 23 (30) 
* Number of mice in parentheses, 
I Significantly different from C57BL/6J, + / + (/)< 0 01). 
* Significantly different from untreated C57BL/6J,bg/bg mice, (/> < 0 02). 
dependent albuminuria, that is at its maximum 24 h after administration of anti­
body (4, 26). This albuminuria develops after a transient glomerular influx of P M N 
during the first hours. Table I shows that doses of R a M - G B M antibody ranging 
from 2.8 to 22 mg induced an albuminuria in control C57BL/6J, + /+ mice that 
was related to the amount of antibody given. By contrast, the albuminuria of 
C57BL/6J,bg/bg mice was not significantly different from the physiological al­
buminuria at nearly all doses of antibody used. Only at the highest antibody dose 
of 22 mg was the albuminuria in beige mice significantly higher than that in un­
treated animals of the same strain {p < 0.02). Table I also shows that the physiolog-
F I C U R E 1. Detection of rabbit Ig (A) and mouse C 3 (β) by direct immunofluorescence at 2 h 
after injection of 5.3 mg of R a M - G B M antibody into a C57BL/6J,bg/bg mouse. Rabbit Ig is 
localized in a strong linear pattern along the G B M (A), whereas mouse C 3 is distributed in a 
more fine granular pattern (Β). {A) χ 160, (Β) χ 200. 
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T A B L E II 
Immunofluorescence Findings in C57BL/6J,bg/bg Mice 
2 h after Injection of RaM-GBM 
Do Rabbit IgG ' Mouse C3Í Fibrin 
"4' 
2.8 
11 
+ + + 
+ + + + 
+ 
+ + / + + 
Identical results were obtained in C57BL/6J, + / + control mice. 
* Linear staining. 
Í Fine granular staining along the capillary walls. 
ical albumin excretion in untreated beige mice was slightly, but significantly, higher 
than that of normal control mice. 
Histology. We studied the glomerular inflammatory response in beige and con-
trol mice by injecting a low dose (2.8 mg) and a high dose (11 mg) of R a M - G B M 
antibody. By immunofluorescence the two mouse strains showed comparable linear 
binding of rabbit Ig (Fig. 1 A), and a fine granular binding of the third component 
of the complement system to the glomerular capillary wall (Fig. 1 В and Table II). 
As in our previous studies, the amount of mouse C3 was greatly diminished after 
24 h, while at that time small fibrin deposits had appeared in some glomerular loops. 
2 h after injection of the antibodies a massive glomerular influx of P M N s was seen, 
the number of which was related to the dose of antibody (Fig. 2). Beige mice showed 
a more prominent influx of P M N in their glomeruli than control mice, especially 
at the low dose of antibody (Table III). 24 h after the injection of antibody the number 
of intraglomerular P M N had returned to normal values in both groups. The glo­
merular changes at 2 h were studied in more detail by electron microscopy. In both 
FIGURE 2. A prominent influx 
of polymorphonuclear granulo­
cytes (arrows) is seen in a glomer­
ulus of a C57BL/6J,bg/bg mouse 
by light microscopy at 2 h after 
injection of 5.3 mg of R a M -
G B M antibody (Periodic Schiff 
staining, χ 210). 
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T A B L E III 
Influx oj PMN m the Glomeruli 2 h after Іпіта епош 
Injection of RaM-GBM 
P M N per glomerulus" 
RaM-GBM C57BL/6J,bg/bg C57BL/bJ, + / + 
mg 
2 8 7 2 ± 4 8 3 2 ± 1 5 
11 9 1 ± 1 0 7 9 ± 2 8 
None 0 2 ± 0 1 0 1 ± 0.1 
* P M N in 40 glomeruli per mouse were counted The number is expressed as 
the mean ± SO of PMN per glomerulus of four mice per experimental group 
strains of mice P M N were observed, either lying free in the glomerular capillary 
lumina, or making contacts of varying extent with the inner side of the GBM, pushing 
aside or damaging the endothelial cells (Fig. 3). In some glomerular loops, P M N 
were seen making contact with the GBM through long pseudopods penetrating the 
endothelial fenestrae (Fig. 4); at other sites P M N were lying in close apposition to 
a denuded G B M . Occasionally, a few platelets were also seen attached to the GBM. 
Endothelial cells more remote from the sites of GBM-fixed P M N had a normal ap­
pearance or were swollen and detached from the underlying basement membrane. 
Electron dense deposits or fibrin fibrils were not observed at this stage of the disease. 
Thus, despite the absence of albuminuria in beige mice, comparable damage of en­
dothelial cells was noted with P M N lying in close contact to the G M B . 
Superoxide Production, Elastase Content, and GBM-degrading Capacity of Peritoneal PMN. 
Since differences in R O M released from activated P M N s could theoretically also 
explain the observed difference in albuminuria between normal and beige mice, we 
measured the superoxide production of peritoneal P M N s in both strains. In addi­
tion, we measured the elastase content of peritoneal P M N s in order to verify the 
reported deficiency of neutral proteases in the beige mice (24). Table IV shows that 
PMA-induced superoxide production of beige P M N s is not significantly different 
from that in normal mice. We could confirm the deficiency of neutral proteinases 
in the beige mice. The elastase content was shown to be sixfold lower as compared 
with normal C57BL/6 mice. 
The capacity of PMN-extracts of both strains to degrade purified murine G B M 
fragments is shown in Table V. FITC-labeled, insoluble G B M was readily broken 
down by a PMN-extract from control mice, whereas the extracts from beige P M N 
were significantly less effective. Pretreatment of the P M N extracts of beige and con­
trol mice with 1 m M of the serine proteinase inhibitor P M S F completely prevented 
the breakdown of GBM, indicating that the enzymes involved belong to the class 
of serine proteinases. 
Effects of ROM Scavengers on Albuminuria in B10.D2 New Mice. As shown in the 
previous section, superoxide production by beige mice was not significantly different 
from control mice, suggesting that R O M are not responsible for the difference in 
glomerular injury between the two strains. It is, however, still possible that R O M 
are involved in inducing the observed damage, by acting synergistically with neutral 
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KKAJRK Ч Klt't iron ph(>tümicroi(raph ol a gloraerular capiUary loop oi a C57BLy6J,bg/bg mouse 
al 2 h aller adrninisiralion ol 2 К т ц ol R a M - G B M anlilxxly showirn; Iwo polymorphonuclear 
granulocytea ( I ' M N ) in ihe capillary lumen O n e of the P M N is directly attached to the inner 
side ol ihe ( i B M (armwheads) replacing the endothelium. T h e olher P M N containing a ціапі 
lysosome (tulernk) in Us cytoplasm lies against an m l a i l endothelial layer Identical resulls, were 
seen in C 5 7 B I J / 6 J , + / + (conirol) m u e injected wilh ihe same amount ol R a M - G B M antibody 
( χ 16,640) Abbreviations: US, ur inary spaee; Efi, foot processes of ihe visceral epithelial cell; 
Cap, (apillary lumen. 
proteases. To investigate the possible role of R O M , we tested the effect of scavengers 
of hydrogen peroxide and hydroxyl radicals in our original anti-GBM nephritis model 
in B10.D2 new mice. Neither catalase, which eliminates hydrogen peroxide, nor DFO, 
which chelates iron and thereby prevents hydroxyl radical formation, were able to 
prevent albuminuria in anti-GBM nephritis, as shown in Table VI. 
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FIGURE 4. Electron photomicrograph of a glomerular capillary loop of a C57BL/6J,bg/bg mouse 
2 h after administration of 2 8 mg of R a M - G B M antibody The endothelial cell {End) has been 
partly pushed aside by a P M N . that adheres directly to the denuded surface of the G B M . Pseu-
dopods of the same P M N also make contact with the G B M through endothelial fenestrae (arrow-
head). T h e endothelial cell layer between these two points of contact is intact (x 15,300), Abbrevi-
ations: US, ur inary space. Ep, foot processes of the visceral epithelial cell. Cap, capillary lumen 
T A B L E I V 
Superoxide Production and Proteinase Content of PMN from 
C57BL/6J,bg/bg and C57BL/6J, + / + Mice 
C57BL/6J,bg/bg C57BL/6J, + / + 
Superoxide production* 
(nmol/106/min) 3.4 ± 0.5 2.9 ± 0 7 
Elastase (pKatal/106)t 6 ± 1 37 ± 5 
* Figures represent means ± SD of six mice. 
I Figures represent the results of separate measurements on three pools of five 
peritoneal exudates 
T A B L E V 
Degradation of GBM by PMN Extracts from C57BL/6f,bg/bg 
and C57BL/6J. + / + Mice 
PMN extract 
obtained from: Treatment Degradation of GBM 
% 
Buffer - 3 ± 2 (4)* 
Beige mice - 10 ± 5 (4)t 
Control mice - 34 ± 13 (6) 
Beige mice PMSF 4 ± 2 (4) 
Control mice PMSF 4 ± 2 (6)* 
* Number of experiments in parentheses 
* Significantly different from degradation by normal PMN, (p < 0.01). 
S Significantly different from degradation by normal PMN without PMSF (p 
< 0 01) 
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T A B L E VI 
Effect of Inhibitors of Reactive Oxygen Metabolites on Albuminuria m 
Anti-GBM Nephritis in BIO D2 New Mice 
Inhibitor' 
Catatase 
Catalase 
D F O 
D F O 
None 
RaM-Gl 
5 3 
5 3 
5 3 
BM Albuminuria1 
μ^/ΙΗ h 
2,650 ± 578 (8) 
27 ± 21 (6) 
2,808 ± 1,626(6) 
106 ± 79 (5) 
2,769 ± 1,062 (8) 
* 10 mg of catalase were injected intravenously aloniç with the anti-GBM anti-
bodies DFO was ці сп subcutaneously (7 5 mg) and intravenously (2 J mg) 
before the administration of the antibodies 
* Albumin excretion measured on urine samples obtained from 6-24 h after m-
jettion of the antibodies Number of mice examined in parentheses 
Discussion 
The data presented in this paper demonstrate the involvement of leukocytic neu­
tral proteinases in the induction of albuminuria during the acute phase of anti-GBM 
nephritis in the mouse. It is shown that mice deficient in leukocyte clastase do not 
exhibit significant albuminuria in the early phase of anti-GBM nephritis compared 
with normal mice, notwithstanding an identical glomerular infiltration of P M N in 
both groups. Surprisingly, electron microscopy showed many P M N s attached to the 
denuded inner side of the G B M concomitant with damage to endothelial cells in 
both strains of mice. These results suggest that unlike the findings in other models 
with endothelial injury (32, 33), glomerular endothelial damage per se does not lead 
to an enhanced glomerular permeability for proteins. Other mediators than neutral 
proteinases seem to be responsible for the destruction of the endothelia. This is sup­
ported by recent observations in rat kidneys, where perfusion with elastase and 
cathepsin G led to proteinuria without any visible injury of endothelial cells (34). 
No definite role of R O M , the generation of which is not inhibited in P M N of beige 
mice, was found in the induction of albuminuria in this model, although they may 
have been involved in the observed cell injury. In vitro studies have demonstrated 
that R O M are indeed directly cytotoxic to a wide variety of normal cells including 
endothelial cells (35). 
Several R O M have been implicated in the induction οΓΡΜΝ-dependent glomer­
ular disease in rats, such as hydrogen peroxide, hydroxyl radicals, and hypohalous 
acid, the toxic derivatives of the reaction of the leukocytic myeloperoxidase with 
hydrogen peroxide (5, 6, 11, 12). The evidence of their action is largely based on 
the effects of R O M scavengers on the glomerular injury by circulating P M N . In 
our murine model the albuminuria was not inhibited by catalase, which catalyzes 
the conversion of hydrogen peroxide to water and oxygen, nor by the iron chelator 
DFO, which prevents the generation of hydroxyl radicals from hydrogen peroxide. 
Equivalent dosages of their agents in rats have been shown to be highly effective 
(6). Whether this discrepancy is caused by differences in effector mechanisms be­
tween rats and mice, or by insufficient delivery of the scavengers to the site of action 
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in mice, remains to be investigated. In vitro superoxide production by activated P M N 
of beige mice was not significantly different from control values. Recently, it was 
shown by others that also hydrogen peroxide production in both strains was similar 
(36). They observed, however, a redut ed production of hydroxy! radicals in vitro 
by P M N of beige mice, a phenomenon that is not easy to explain, since hydroxyl 
radicals are derived from hydrogen peroxide, which is produced in equal amounts (36). 
Several studies both in man and in experimental animals suggest a role for neutral 
proteinases in glomerular damage. It has been shown that lysosomal enzymes from 
P M N s , especially elastase and cathcpsin G, can digest G B M in vitro (8, 9, 15, 21, 
22, 37). In addition, PMN-derived neutral proteinases along with fragments of the 
G B M have been detected in the urine of rabbits with a passive anti-GBM nephritis 
(8). Both these components have also been found in the urine of patients with a prolifer­
ative glomerulonephritis in which P M N were involved (38). Recently, a linear corre­
lation between urinary excretion of neutral proteinases and proteinuria was found 
in a model of accelerated autologous phase anti-GBM nephritis and in aminonucleoside 
nephrosis (39) In these latter models, but also in the above-mentioned clinical study, 
the neutral proteinases recovered from urine were able to degrade G B M in vitro. 
It has also been shown that administration of amidine-type proteinase inhibitors 
in vivo protected against glomerular injury during immune complex-mediated glo­
merulonephritis (40). It was suggested that these inhibitors act on proteinases, such 
as Hageman factor, kallikrein, plasminogen activator and plasmin, and thereby 
dampen the inflammatory response More direct evidence that neutral serine pro­
teinases can mediate glomerular damage stems from the recent finding that perfu­
sion of rat kidneys with elastase and cathcpsin G caused massive proteinuria (34). 
The possible role of P M N neutral proteinases has been investigated in several other 
models of inflammation. Using the beige mouse as a model, no significant differ­
ences were found in experimental alveolitis, compared with normal mice (41). In 
a reversed passive Arthus reaction, used as a model of immune complex vasculitis, 
no difference was found in the degree of vascular damage (42). In P M N from humans 
with emphysema an enhanced Chemotaxis in response to a chemotactic peptide was 
found compared with control cells. P M N from patients with bronchiectasis contained 
significantly more of the serine proteinase elastase. In both these forms of chronic 
obstructive lung disease this "overload" of P M N may have contributed to their greater 
extracellular proteolysis (43). These findings illustrate that the role of neutral pro­
teinases might be dependent on the model, i.e , the type of inflammation (tissue lo­
calization), and the animal that is used. 
There are several factors that enhance the role of P M N neutral proteinases as 
important mediators in glomerular damage. The close apposition of the P M N to 
the G B M facilitates not only the binding of released enzymes to it, but may also 
exclude plasma proteinase inhibitors such as α-1-proteinase inhibitor and α-1-anti-
chymotrypsin from the site of enzyme action. Binding of elastase to its substrate 
is furthermore promoted by virtue of their cationic nature (44). Since this enzyme 
has an isoelectric point higher than 8.8, it will exhibit affinity for the G B M , which 
is negatively charged due to the glycosaminoglycan chains of the heparan sulphate 
proteoglycans. Affinity of cationic proteins and exclusion of anionic protease inhibi­
tors from G B M might be analogous to the interaction of this protein with negatively 
charged cartilage matrix as we have shown before (45, 46). 
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We would propose that this particular anti-GBM nephritis model is a useful 
screening system for antiproteinase drugs, that ultimately might prove to be effec­
tive in a number of human diseases including pulmonary emphysema, arthritis and 
glomerulonephritis 
S u m m a r y 
Antiglomerular basement membrane (GBM) nephritis with massive albuminuria 
can be induced in mice by injection of heterologous antibodies against mouse GBM 
The albuminuria and the glomerular lesions in this model are not mediated by com­
plement, but are dependent on the presence of polymorphonuclear granulocytes 
( P M N ) in the glomeruli Neutral serine proteinases and reactive oxygen metabolites 
produced by activated P M N have been implicated as agents contributing to tissue 
damage We examined the role of leukocytic neutral proteinases by comparing the 
glomerular damage and albuminuria after injection of rabbit anti-mouse GBM an­
tibodies in normal control mice(C57BL/6J, + / + ) and in beige mice (C57BL/6J,bg/bg) 
in which P M N are deficient of the neutral proteinases elastase and cathepsin G 
The dose-dependent albuminuria that occurred in control mice after injection of 
1 4-22 mg of anti-GBM antibodies was not observed in beige mice, despite a com­
parable influx of P M N s in the glomeruli By electron microscopy both strains showed 
a similar attachment of P M N to the denuded GBM together with swelling and necrosis 
of endothelial cells Elastase activity of extracts from P M N of beige mice was only 
10-15% of the activity of control mice In vitro, G B M degradation by P M N extracts 
of beige mice was 70% lower than that seen in control experiments P M N s of beige 
and control mice showed no differences in superoxide production In addition, ad­
ministration of scavengers of reactive oxygen metabolites, such as catalase and des-
fernoxamine, did not prevent the albuminuria in this model These findings sup­
port the important contribution of leukocytic neutral proteinases to the induction 
of albuminuria in the acute phase of anti-GBM nephritis in the mouse 
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CYCLOSPORINE A (CsA) has potent immunosuppressive properties, as has 
been demonstrated in clinical organ trans-
plantation.1 Also, in certain experimental and 
human autoimmune diseases, it has been 
shown to be therapeutically effective.2*3 Dur-
ing treatment with CsA in murine and human 
systemic lupus erythematosus, a decrease in 
proteinuria was observed in some but not all 
cases.2,4"8 In the acute serum sickness model it 
was also shown that CsA could prevent pro-
teinuria and proliferative glomerular lesions, 
although clearance of antigen, size, level and 
clearance of immune complexes, levels of 
antibodies, complement consumption, and 
glomerular deposition of antibodies and 
complement were not decreased in CsA-
treated animals.' So it appeared that, despite 
a similar immunologic attack on the glomeru-
lus, CsA could prevent the consequences 
thereof, ie, proteinuria and cellular prolifera-
tion. The explanation for this antiphlogistic 
rather than immunosuppressive effect of CsA 
might be that CsA can inhibit interleukine 
release profoundly. On the basis of these 
observations, CsA was subsequently used in 
patients with steroid-resistant or steroid-
dependent nephrotic syndrome secondary to 
primary nonproliferative forms of glomeru-
lonephritis. In the majority of patients with 
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minimal-change glomerulopathy and in 50% 
of the cases with focal glomerulosclerosis, 
proteinuria disappeared.10 In general, the 
decrease in proteinuria occurred within a few 
weeks after the start of treatment; however 
discontinuation of drug therapy led in most 
cases to a prompt recurrence of proteinuria. 
This immediate reaction to the introduction 
and withdrawal of drug therapy makes it very 
unlikely that the immunosuppressive proper-
ties are responsible for the antiproteinuric 
effect. Hypothetically it could be either 
mediated by hemodynamic changes (de-
creases in the glomerular filtration rate 
(GFR) and filtration fraction) or changes in 
glomerular basement membrane (GBM) 
permselectivity characteristics. To study this 
antiproteinuric effect in more detail, we ana-
lyzed the influence of CsA on albuminuria in 
a passive model of anti-GBM nephritis in the 
mouse. In the heterologous phase of this mod-
el, binding of the injected antibodies leads to 
an acute exudative glomerulonephritis char-
acterized by an influx of polymorphonuclear 
granulocytes (PMNs), intravascular coagula-
tion and necrosis, and albuminuria." 
CsA therapy decreased not only albumin-
uria but also the GFR in this model. The 
decrease in albuminuria outweighed the 
decrease in GFR. Therefore, the antiprotein-
uric effects of CsA are probably mediated by 
both a reduction in GFR and changes in 
glomerular permselectivity. 
MATERIALS AND METHODS 
Animals 
CS7BL10 mice, originally obtained from the Jackson 
Laboratory, Bar Harbor, ME, were kept in our laboratory 
by continuous brother-sister matings. For all experiments 
we used male mice at the ages of 3 to 4 months. Randomly 
bred Swiss mice were purchased from the Central Insti-
Trmaptantation Proceedings. Vol XX. No 3, Suppl 4 (June). 198B: pp 304-308 
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tute for the Breeding of Laboratory Animals, TNO, 
Zeist, The Netherlands Rabbits used for the preparation 
of the antiserum and nonimmune IgG were bought from a 
local breeder 
Preparation ofAnti-GBM Antibodies 
Anlimouse GBM antibodies were prepared in rabbits 
as described before"12 The rabbit anlimouse GBM 
(RaM GBM) antiserum and nonimmune rabbit IgG 
(RIgG) were punned on a Sepharose 4B-protein A 
column (Pharmacia Fine Chemicals, Uppsala, Sweden) 
and concentrated 
CsA Treatment 
CsA dissolved in 0 1 mL olive oil was given by gavage 
daily in a dose of 75 mg/kg body weight from days 1 to 4 
Control animals received 0 I mL olive oil orally 
Induction of Anti-GBM Nephritis 
At day 4 RaM-GBM was injected in a dose of S 3 mg 
intravenously (groups I and II) Control animals (groups 
III and IV) at day 4 received RIgG (S 3 mg) intravenous­
ly Six hours after the injection of RaM-GBM or RIgG, 
the mice were placed in metabolic cages for 18 hours for 
urine collection to measure albuminuria At two and 24 
hours after the injection of RaM-GBM or RIgG, three 
and 12 animals respectively were bled for the determina­
tion of creatinine and albumin levels and killed for 
immunohistology of the kidney Serum creatinine levels 
were measured in a CoBas Bio autoanalyzer (Roche, 
Basel, Switzerland) Serum albumin concentrations were 
determined by the bromcresol green method " Urinary 
albumin concentrations were determined by radial immu­
nodiffusion with goat anlimouse albumin as described 
before12 The mean (±SD) albuminuria in normal 
untreated mice in our laboratory is 22 ± 33 Mg/18 h " 
Histology 
Slices of kidney tissues were fixed in Bourn's solution, 
dehydrated, and embedded in paraplast (Amstelstad, 
Amsterdam), and 4-дт sections were stained with hema­
toxylin and eosin, PAS, silver methenamine, and chrome 
aniline blue " l 2 · 1 4 The glomerular influx of PMNs was 
determined by the counting of PMNs in at least 40 
glomeruli per mouse and expressed as the average number 
of PMNs per glomerulus Immunofluorescence was per­
formed on kidney tissue that was snap-frozen in liquid 
nitrogen Two-micrometer-thick cryostat sections were 
stained directly with fluorescein isothiocyanate-labeled 
swine antirabbit IgG (Dako, Copenhagen), goat anti-
mouse IgG (heavy and light chains), C3 (both from 
Cappe! Laboratories, West Chester, PA), and rabbit 
antihuman fibrinogen (Dako), which cross reacts with 
mouse fibrinogen The sections were examined in a Leitz 
fluorescence microscope equipped with Ploemopak epi-
lumination, and the staining intensity was recorded semi-
quantilatively (on a scale from 0 to 4 + ) as described 
before 'J 
Estimation ofGFR 
The GFR was measured by using "Cr-EDTA as 
described before for the measurement of GFR in mice " 
Twelve microcuries of "Cr-EDTA (A mer sham Interna­
tional, Amersham, UK) in 0 3 mL saline was injected 
intravenously Pilot experiments revealed that a measure­
ment of serum radioactivity 45 minutes after injection 
yielded similar results if compared with estimations based 
on multiple serum collections at 10, 20, 30, 60, 90, and 
120 min after injection For this single point GFR estima­
tion, a calibrated 50-μΙ_ blood sample was taken 45 
minutes after the injection of "Cr-EDTA After 2 mL 
saline was added to the blood sample, radioactivity was 
measured in a universal gamma scintillation counter 
(LKB, Turku, Finland) A relative estimate of GFR was 
calculated according to the following formula GFR -
injected "Cr-EDTA dose (counts per minute) per mouse 
body weight at injection (grams)/counts per minute in 
blood sample at 45 minutes With this single-point tech­
nique repeated measurements in individual mice at dif­
ferent occasions revealed an interassay variation of 
12 9% To evaluate the effect of CsA or olive oil on the 
GFR, GFR measurements were performed in all animals 
before any treatment was given at day -1 (control value) 
and at day 4, 15 hours (midpoint of time of urine 
collection) after the injection of RaM-GBM or RIgG 
(experimental value) 
Experimental Design 
To ensure optimal hydration all animals received I mL 
saline intrapentoneally (IP) daily from days 0 to 4 and 2 
mL saline IP at day 4, six hours after the injection of 
RaM-GBM or RIgG Five groups of mice were studied 
group 0, hydration regimen only (n - 9), group I, CsA 
daily from day 1 and injection of 5 3 mg RaM-GBM at 
day 4 (n - 15), group II, olive oil daily from day 1 and 
injection of 5 3 mg RaM-GBM at day 4 (n - 15), group 
III, CsA daily from day 1 and injection of 5 3 mg RIgG at 
day 4 (n - 15), and group IV, olive oil daily from day 1 
and injection of 5 3 mg RIgG at day 4 (n - 15) In 
addition, eight mice in each treatment group (I to IV) 
were used for estimation of the GFR at day - 1 and 15 
hours after the injection at day 4 
Statistical Analysis 
For statistical analysis Wilcoxon's rank sum test and 
Student's ι test were used when appropriate Ρ values 
< 05 were considered significant All values are expressed 
as means ± SD 
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Т а Ы · 1 . A l b u m i n u r i e and Ρ Ε
Μ
 i n t h e Different Groupa 
Group 
0 
1 
II 
III 
IV 
Enpanmwital 
Protocol 
Hycfration only 
RaM-GBM* + CsA 
RaM-GBM + oliva oil 
R I Q G · + CsA 
RlgG + olive oil 
π 
6 
11 
12 
12 
12 
АІЬитігнла 
(mg/18 h) 
0.1 ± 0.1 
Ι.β ± 1.8t 
9.8 ± 3.4 
0.1 ± 0.1 
0.1 ± 0 . 0 
«» 
(«1 
— 
0.17 ± 0 . 1 6 t 
0 . 5 8 ± 0 . 2 6 
— 
— 
•Injected et dey 4 (5 3 m g IgGI. 
t G r o u p I v i l , P < .05. 
RESULTS 
Induction of the heterologous phase of anti-
GBM nephritis by injecting RaM-GBM anti­
bodies leads to a severe albuminuria of 9.8 ± 
3.4 mg/18 h (Table 1, group II). CsA treat­
ment of mice receiving RaM-GBM (group I) 
caused a significant reduction (P < .0005) in 
albuminuria to 1.6 ± 1.8 mg/18 h. In mice 
injected with RlgG with either CsA or olive 
oil, albuminuria did not exceed 0.1 mg/18 h 
(groups III and IV). 
Histological analysis in mice injected with 
the RaM-GBM antiserum and treated with 
olive oil (group II) revealed an early and 
prominent influx of PMNs in the glomeruli at 
two hours (Table 2). CsA treatment (group I) 
did not influence this PMN influx. No histo­
logical signs of tubular necrosis were found, 
although in mice treated with CsA (groups I 
and III) the tubular cells were swollen and 
showed a coarse nonisovoiumetric vacuoliza­
tion. Two and 24 hours after the administra­
tion of RaM-GBM a strong linear binding of 
rabbit IgG along the glomerular cajpillary 
walls was observed in both CsA- and olive 
oil-treated groups (groups I and II). In both 
groups, at two hours a fine granular binding of 
C3 in the glomerular capillary wall was 
detected, which was considerably less at 24 
hours. At two hours a few deposits of fibrin 
were found in some glomeruli. At 24 hours, 
these deposits had increased in both CsA-
treated (group I) and olive oil-treated mice 
(group II). In mice injected with nonimmune 
rabbit IgG (groups III and IV) no depositions 
of RlgG, fibrin, or mouse C3 in the capillary 
wall were found. The essential immunohisto-
logical findings are summarized in Table 2. 
CsA induced a decrease in the GFR in mice 
injected with RaM-GBM as well as in mice 
injected with RlgG. Contrary to this, in mice 
treated with olive oil the GFR remained 
unchanged (Fig 1 ). The reduction in albumin­
uria in group I can probably not be explained 
solely by the decrease in GFR because albu­
min excretion corrected for GFR (ΡΕ
ΑΛ
) was 
still significantly lower in CsA-treated mice 
compared with olive oil-treated mice (Table 
! ) • 
DISCUSSION 
CsA therapy can reduce proteinuria in sev­
eral experimental and human forms of glo-
Table 2 . Immune Reactanta Deposited in t h e G lomerular Capillary W a l l and Inf lu i i of P M N · in t h e Glomeruli After 
I n j e c t i o n of 6.3 mg R a M - G B M 
Eqnnmentai 
Group 
Tim· After 
Injection (h) 
Rabtiit 
IgG 
Mousa 
C3 
Intrsglommilar 
PMN Influì· 
Group 1 (CsA) 
Group II (olive oil) 
2 
24 
2 
24 
+ + + + 
+ + + + 
+ + + + 
+ + + + 
+ + 
+ 
+ + 
+ 
± 
+ 
± 
+ + 
7.0 ± 2 .0 
0.5 ± 0.1 
7.2 ± 0 .6 
0.4 ± 0 .2 
•Mean ± SO per glomerulus of three mice per eaperimental group at each time pomt. 
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CFR 
Carbitrary 
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Group IV 
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Fig 1. Estimations of the GFR in arbitrary unita 
(±SD) at day - 1 (control value. C) and at day 4. 1Б 
hours after the intravenous injection of rabbit anti-
mouse GBM or nonimmune RlgG (енрегітетаі value. 
E). All groups consisted of eight mice. In CsA-treated 
animals (groups I and III), the GFR et day 4 (E) differs 
significantly ( · . Ρ < .0006) from the GFR at day - 1 (C). 
in contrast to measurements in olive oil-treeted animals 
(groups II and IV). 
merulonephritis. In experimental serum sick­
ness this reduction was not accompanied by a 
decrease in the immunologic injury to the 
glomerulus.9 Furthermore, CsA treatment 
can inhibit proteinuria in humans with focal 
and segmental glomerulosclerosis10 in which 
proteinuria occurs without signs of inflamma­
tion. Therefore, CsA seems to have an anti-
proteinuric effect that is not related to its 
immunosuppressive properties. In our model 
CsA did not modify the acute glomerular 
lesions as assessed by light microscopy and 
immunohistology. Despite this, an impressive 
reduction in albuminuria occurred during 
CsA treatment. 
CsA has profound effects on renal hemody­
namics in animals and humans. It decreases 
the GFR and renal blood flow, probably by 
vasoconstriction of the afferent glomerular 
arteriole."17 In our model CsA therapy also 
reduced the GFR by approximately 50%. 
Therefore, the reduction in albuminuria could 
be the result of a decreased filtration of albu­
min; however, decreased filtration alone can­
not fully explain the reduction of albuminuria 
because FE l lb (albumin excretion corrected 
for GFR) was also significantly reduced in the 
CsA-treated group (0.17% ± 0.16% ν 
0.58% ±0.56%, Ρ <.Ol). 
Other mechanisms by which CsA could 
exert its antiproteinuric effect besides GFR 
reduction are far from clear. Its antiprotein­
uric effect resembles that of the various non­
steroidal antiinflammatory drugs (NSAIDs), 
especially of indomethacin, because both 
drugs reduce proteinuria more than they 
reduce the GFR."" The antiproteinuric 
effects and reduction in the GFR by NSAIDs 
are attributed to inhibition of prostaglandin 
synthesis. CsA can also inhibit renal prosta­
glandin synthesis.20 It is therefore conceivable 
that interference with the renal prostaglandin 
metabolism is responsible for the antiprotein­
uric effect of CsA. Another possibility is that 
CsA inhibits mediator release from PMNs or 
resident glomerular cells. Albuminuria in this 
anti-GBM model in the mouse is dependent on 
PMNs because induction of granulocytopenia 
prevents its development (submitted for publi­
cation). CsA may inhibit the PMN-mediated 
damage of the GBM and thereby prevent 
albuminuria. 
In conclusion, our study shows that CsA 
can have a profound antiproteinuric effect 
that is not related to its immunosuppressive 
action and is mediated by a reduction of the 
GFR and probably also by a change in glo­
merular permselectivity. 
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DISCUSSION AND SUMMARY 
In experimental models of glomerulonephritis, the histologi-
cal changes that follow the binding of antibody in the 
glomerulus and the subsequent activation of mediator systems, 
are largely determined by the site in the glomerulus where 
the antibody is bound (1) . Antibodies located at the outer, 
subepithelial side of the GBM cause a non-proliferative 
glomerulonephritis. Activated complement factors and also 
cytokines, produced locally by the glomerular visceral 
epithelial cells, mediate the proteinuria in this form of 
nephritis (2) . On the other hand, antibodies fixed at the 
inner side of the capillary wall, whether subendothelially or 
in the mesangium, are accessible not only to soluble media-
tors, but also to inflammatory cells. This results in an 
exsudative and/or proliferative form of glomerulonephritis, 
accompanied by proteinuria. Anti-GBM nephritis clearly 
belongs to the latter group of nephritides. The administered 
heterologous anti-GBM antibodies bind to structural compo-
nents at the inner side of the GBM. This is followed by 
immediate activation of complement, and a transient influx of 
neutrophils, which push aside the endothelial cells and 
adhere to the glomerular capillary wall. An extensive number 
of studies performed in several species, have indeed revealed 
that such a complement-dependent. PMN-dependent mechanism 
forms the major pathway leading to the glomerular injury and 
proteinuria in this model (3-12). 
Damage can also be caused via two other mechanisms in this 
model, dependent on the amount and subclass of the antibo-
dies, the animal species, and the experimental procedure used 
(Table I). Antibody alone can induce proteinuria via a 
complement- and PMN-independent mechanism, when non-comple-
ment-fixing antibodies are used (13-27) . In most cases, as 
seen particularly in guinea pigs, the resulting lesions are 
characterized by a massive but transient increase in glomeru-
lar permeability in the absence of morphologic signs of 
inflammation. In the classic studies of the early sixties, it 
has also been shown that complement-fixing anti-GBM antibo-
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dies can induce proteinuria in the absence of complement 
activation, when given in large doses to complement-depleted 
or complement-deficient animals (4-12). Similar to the 
studies with non-complement-fixing antibodies in the guinea 
pigs, the glomerular lesions are minimal, and the proteinuria 
is less severe. It has not been clarified whether all types 
of anti-GBM antibody can cause this complement- and PMN-
independent increase in glomerular permeability or whether 
this effect is restricted to a special subclass. A few 
studies report on a third complement-dependent. PMN-indepen-
dent mechanism in the heterologous phase (26,28,29). In one 
of these studies Сб-deficient rabbits failed to develop 
severe proteinuria after the injection of anti-GBM antibody, 
Table I. Mechanisms involved in the induction of proteinuria 
and glomerular capillary wall damage during the 
heterologous phase of passive anti-GBM nephritis. 
Summary of reported animal studies 
I. Complement- and PMN-dependent 
sheep anti-rabbit (4-8) 
rabbit anti-rat (9-12) 
II. Complement- and PMN-independent 
A. Non complement-fixing antibodies 
duck anti-rabbit (13) 
duck anti-rat (4) 
sheep Ύ2 anti-rabbit (14) 
sheep у2 anti-rat (6) 
sheep у2 anti-guinea pig (15) 
guinea pig γ^ anti-rat (16,17) 
rabbit anti-rat Ffab·^ (18) 
guinea pig -n anti-rat F(ab,)2 (19) 
sheep γ^ anti-guinea pig F(abl)2 (15) 
B. Complement-fixing antibodies 
1. sheep anti-guinea pig (20,15) 
rabbit anti-rat (21) 
sheep anti-rat (22-25) 
sheep anti-rabbit (26) 
mouse anti-rabbit (27) 
2. sheep anti-rabbit (4-8) 
rabbit anti-rat (9-12) 
III. Complement-dependent, PMN-independent 
sheep anti-rabbit (26,28) 
sheep anti-rat (29) 
IV. Complement-independent, PMN-dependent 
goat anti-mouse (This thesis) 
rabbit anti-mouse (This thesis) 
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despite the presence in the glomeruli of antibody, C3, and 
PMNs in numbers similar to those observed in complement-
normal control animals, which all showed heavy proteinuria 
(28). These results suggested that in this model activation 
of the terminal complement factors, the so-called membrane 
attack complex (MAC), was required for the induction of 
injury in the heterologous phase. Also, the presence of many 
PMNs in the absence of proteinuria was considered a strong 
argument for a direct effect of complement-independent 
inflammatory cells. More direct evidence for the existence of 
such a mechanism can be derived from studies of Boyce et al, 
who were able to induce proteinuria in the isolated rat 
kidney perfused with anti-GBM antibody and complement (29) . 
Subsequently, they demonstrated that an anti-GBM induced, 
dose-dependent proteinuria in PMN-depleted rabbits could be 
prevented by complement depletion (26). As suggested by 
Couser, there is a fourth mechanism, that can, at least 
theoretically, occur during the early phase of anti-GBM 
nephritis, i.e. a complement-independent. PMN-dependent renal 
damage. However, the existence of such a mechanism was not 
reported sofar. 
The successful development of a model of anti-GBM nephritis 
in the mouse, with a dose-dependent proteinuria in the 
heterologous phase, enabled us to investigate the mechanisms 
of renal damage in this species. The availability of its many 
inbred strains, that could be used in studying mediators 
responsible for morphologic and clinical symptoms of this 
phase, such as C5-deficient strains and beige mice deficient 
of leukocytic neutral proteinases (30-32), made such an 
approach particularly attractive. The morphological study in 
this model had shown that heterologous anti-mouse GBM antibo-
dies immediately bind in a linear fashion along the GBM. They 
subsequently activate complement that becomes fixed in a fine 
granular pattern to the capillary wall. The binding of murine 
C3 is transient and has decreased substantially at day 1. 
This pattern is somewhat different from that in other animal 
species, where the binding of C3 is linear and remains 
present during a much longer period. The activation of C3 is 
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followed by a dose-dependent influx of neutrophils that peaks 
at 2 h, but decreases rapidly thereafter, and has disappeared 
completely at day 1. We could not detect an increase of 
monocytes or lymphocytes in the glomeruli during this exsuda-
tive phase. At the ultrastructural level many neutrophils 
are seen adhering to the inner side of the GBM, while endot-
helial cells are pushed aside or have become necrotic. After 
the decline of the PMN influx, necrosis and signs of intra-
vascular coagulation are seen. The influx of neutrophils 
precedes the albuminuria, that starts at approximately 4 h 
and is maximal between 12 and 24 h. Apart from minor quanti-
tative differences, these morphologic changes are very 
similar to the findings in other animal models and suggest 
that the main mechanism of damage is dependent on complement 
activation and neutrophils. Therefore, we have focussed our 
studies primarily on these two mediator systems. 
By comparing the effects of the injection of antiserum in 
complement-normal B10.D2 new mice and in congenie, congenital 
CS-deficient B10.D2 old mice, both with and without C3 
depletion by treatment with Cobra Venom Factor, we found, 
that a deficiency of C3 and/or C5 did not prevent the influx 
of PMNs, nor the development of histologic glomerular lesi-
ons, or the occurrence of albuminuria. In all cases the 
complete absence of an effective haemolytic complement system 
could be confirmed by a newly devised, sensitive complement 
assay. Our results in C5-deficient mice suggest that not only 
C5a, but other yet unknown factors are responsible for the 
attraction and activation of the neutrophils before they 
adhere to the GBM. Several other factors, such as a derivati-
ve of arachidonic acid, leukotriene B4 (LTB4), and platelet-
activating factor, both synthesized by endothelial cells 
have potent chemotactic activity for neutrophils (33,34). 
In our model the albuminuria appeared to be largely dependent 
on the influx of neutrophils in the glomeruli. The adherence 
of the neutrophils to the glomerular capillary wall required 
an intact Fc fragment since Fiab'^ antibodies failed to 
induce an influx of PMNs or proteinuria. The way in which 
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neutrophils become adherent to the GBM in the absence of 
complement-activation is not entirely clear. It seems likely 
that, in addition to Fc receptor binding, other factors, 
released from inflammatory cells or resident cells, are 
involved. For instance, evidence is accumulating that adhe-
sion molecules that are expressed on endothelial cells under 
the influence of certain cytokines, can participate in the 
adherence process of the neutrophils to the glomerular 
capillary wall (35). 
The results of our complement and PMN studies in the mouse, 
indicate that glomerular damage and proteinuria as a result 
of a complement-independent. PMN-dependent mechanism is not 
merely a theoretical possibility, but actually occurs in 
vivo. This confirms the existence of a fourth pathway (Table 
I). 
Neutrophils are generally assumed to contribute to the 
glomerular injury and the enhanced permeability for proteins 
by the release of lysosomal proteinases and the generation of 
reactive oxygen metabolites (ROMs), acting either alone or 
synergistically (3,36-40). We could demonstrate for the first 
time in an in vivo situation, that the release of leukocytic 
neutral proteinases, elastase and cathepsin G, is responsible 
for the severe albuminuria following the administration of 
anti-GBM antibodies. Reactive oxygen metabolites probably do 
not participate in this process directly, but may be respon-
sible for the initiation of the endothelial cell damage. Our 
conclusions are based on the effects of anti-GBM antibody in 
C57BL/6J,bg/bg (beige) mice, in which neutrophils are defi-
cient for elastase and cathepsin G. The albuminuria occurring 
after injection of the anti-GBM antibodies in control 
C57BL/6J,+/+ mice, was not seen in the beige mouse strain, 
despite a comparable influx of neutrophils and a similar 
severity of endothelial damage in the glomeruli. In addition, 
we found that the in vitro superoxide production of neutro-
phils from beige mice was normal. Inhibition studies with ROM 
scavengers in anti-GBM nephritis induced in B10.D2 new mice, 
suggested that ROMs were not involved in the induction of the 
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albuminuria in this model. 
Although neutrophils, after stimulation, can release a whole 
array of toxic and vasoactive substances into the surroun-
ding, extracellular space, most studies have focussed on the 
tissue destructive properties of lysosomal proteinases and 
certain reactive oxygen metabolites (40-42). It was original-
ly believed that exocytosis particularly of the neutral 
serine proteinases, elastase and cathepsin G, contained in 
the azurophil or primary granules of the neutrophil, caused 
the glomerular lesions and albuminuria (7) . Unfortunately, 
this hypothesis was based only on in vitro data, and on 
indirect evidence. In vivo studies to support this theory 
were lacking. In recent years, substantial evidence has been 
collected, suggesting that highly toxic oxidants generated 
during a "respiratory burst" by neutrophils, may be of 
greater importance in mediating tissue damage than protein-
ases (43-46). Many in vitro and in vivo studies in which ROMs 
were inhibited by specific scavengers suggest a direct toxic 
effect of these oxidants. There are, however, also data 
suggesting a synergistic action of oxidants and proteinases 
(39). Indeed, evidence is now growing, that ROMs do not act 
directly but that they attack locally a series of powerful 
antiproteinases, including al-proteinase-inhibitor, and a2-
microglobulin which normally form a protective shield against 
the action of proteinases (42). By simultaneous activation of 
latent leukocytic proteinases by ROMs, these latter enzymes 
can exert their destructive effects. Our results obtained in 
beige mice are in line with such a supposed mechanism of 
tissue damage. It seems likely, that ROMs which can be 
generated normally by the PMNs of beige mice are responsible 
for the endothelial cell damage that we observed. This damage 
by itself was obviously not sufficient to induce an enhanced 
glomerular permeability in these proteinase-deficient ani-
mals. To induce the full spectrum of renal damage and protei-
nuria, the activity of leukocytic proteinases appeared to be 
necessary. 
Our model of anti-GBM nephritis does not only give more 
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insight into the different mechanism of immune damage, but 
can also be used to examine the effects of therapeutic 
interventions. As a first approach we have tried to answer 
the question of whether cyclosporin A (CsA) could inhibit the 
glomerular damage and proteinuria, which develop after 
injection of anti-GBM antibodies. Besides its potent immuno-
suppressive properties, CsA is known to have also antiphlo-
gistic effects and is now being used as a therapeutic in 
certain experimental and human auto-immune diseases (47-49). 
In most of the glomerular diseases and models examined, CsA 
has an anti-proteinuric effect which may be mediated, either 
by the well-known hemodynamic changes induced by this drug 
(50-51) (decrease of glomerular filtration rate and filtrati-
on fraction), or by alterations in the GBM-permselectivity 
characteristics. In our model CsA administration had no 
influence on the glomerular lesions, but considerably reduced 
the albuminuria. Because CsA also reduced the GFR with 
approximately 50% we concluded that the reduction of albumi-
nuria is partly due to changes in renal haemodynamics. Other 
mechanisms must also contribute to this reduction of albumi-
nuria, since we found that the fractional excretion of 
albumin, i.e. albumin excretion corrected for GFR, was also 
significantly reduced as well in the CsA-treated group. 
Although elucidation of the responsible mechanism needs 
further study, one can already speculate that CsA also has a 
direct or indirect effect on the permselective properties of 
the GBM. 
In conclusion, we have developed a new anti-GBM-model in 
which tissue damage and proteinuria can be induced by a 
complement-independent, PMN-dependent mechanism. We could 
demonstrate that neutral leukocytic proteinases play a 
pivotal role in the induction of proteinuria. This model 
provides the opportunity to further delineate the precise 
mechanism of PMN-induced glomerular damage. It can also be 
used to screen for the activity of ROMs and of neutrophilic 
enzymes. Finally, the dose-dependent proteinuria makes it a 
useful model system to examine the effectiveness of anti-
proteinuric drugs, as is exemplified by our study with 
cyclosporine A. 
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SAMENVATTING 
Door injectie van heterologe antistoffen tegen glomerulaire 
basaalmembranen kan in verschillende diersoorten een glomeru-
lonefritis worden opgewekt (anti-GBM nephritis). De antistof-
fen binden aan structuren gelegen aan de luminale zijde van 
de glomerulaire basaalmembraan. Dit wordt gevolgd door 
activatie van het complement-systeem, influx van polymorpho-
nucleaire granulocyten (PMNs), beschadiging van endotheel en 
intravasale stolling. In een later stadium ontstaan er 
proliferatieve afwijkingen. De acute beschadiging gaat 
gepaard met een verhoogde permeabiliteit, die zich manifes-
teert als Proteinurie. In het algemeen wordt een complement-
afhankelijk, PMN-afhankelijk mechanisme als de belangrijkste 
route beschouwd die leidt tot de glomerulonefritis in dit 
model. Onder bepaalde omstandigheden kan echter ook beschadi-
ging veroorzaakt worden via een complement-afhankelijke, PMN-
onafhankelijke route, of zelfs zonder de betrokkenheid van 
beide mediatorsystemen. Theoretisch is ook nog een vierde 
route mogelijk, die complement-onafhankelijk, maar PMN-
afhankelijk is. Deze werd echter tot dusver in de vroege, 
zgn. heterologe fase van de anti-GBM nefritis nooit aange-
toond. 
De ontwikkeling van een model van anti-GBM nefritis in de 
muis, met een dosis-afhankelijke Proteinurie in de heterologe 
fase, stelde ons in staat de mediatoren van de nierbeschadi-
ging bij deze diersoort te bestuderen. Een voordeel van de 
muis als proefdier is dat vele ingeteelde stammen beschikbaar 
zijn met een goed omschreven immunogenetische achtergrond. 
Wij onderzochten eerst de rol van complement in dit model. 
Voorafgaand hieraan ontwikkelden wij een gevoelige en eenvou-
dig uit te voeren bepaling van haemolytisch muizecomplement. 
Vervolgens vergeleken wij de effecten van antiserum-injecties 
bij complement-normale B10.D2 new muizen en congene, C5-
deficiente B10.D2 old muizen. Soortgelijke experimenten 
werden verricht na het induceren van C3-depletie door voorbe-
handeling met Cobra Venom Factor. Ondanks een volledige 
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deficiëntie van C3 en С5 waren na injectie van anti-GBM serum 
de glomerulaire influx van PMNs en de daaropvolgende glomeru-
laire beschadiging onveranderd aanwezig. Ook het optreden van 
albuminurie werd onder deze omstandigheden niet voorkomen. 
Door muizen te onderwerpen aan totale lichaamsbestraling van 
7.5 Gy verkregen wij een reproduceerbare en vrijwel volledige 
PMN-depletie, die ons in staat stelde de rol van PMNs bij de 
anti-GBM nephritis in dit model te onderzoeken. PMN-depletie 
voorkwam de albuminurie na toediening van een lage dosis 
anti-GBM antistof en leidde tot een sterke vermindering ervan 
bij hoge dosis. De PMN-influx in de glomeruli bedroeg minder 
dan 10% van de controle-waarden. Intravasale stolling en 
necrose bleven uit. Dezelfde resultaten werden verkregen in 
PMN-deplete, C5-deficiente muizen. Injectie van F(ab')2 
fragmenten van de anti-GBM antistof remde de PMN-influx 
eveneens en verminderde de albuminurie tot fysiologische 
waarden. Deze resultaten toonden aan dat voor het ontstaan 
van de albuminurie in dit model de binding van een antistof 
met intact Fe fragment een voorwaarde is. Daarenboven is de 
albuminurie grotendeels, zo niet volledig, afhankelijk van 
influx van PMNs in de glomeruli. Onder de vele experimentele 
modellen van anti-GBM nefritis is dit het eerste, waarin de 
heterologe fase complement-onafhankelijk, maar PMN-afhanke-
lijk is. 
In het algemeen wordt aangenomen dat de PMNs glomerulaire 
beschadiging en verhoogde permeabiliteit veroorzaken via de 
afgifte van lysosomale Proteinasen en de productie van 
reactieve zuurstofmetabolieten. In experimenten met beige 
muizen, die een deficiëntie tonen van de leukocytaire neutra-
le Proteinasen, elastase en cathepsine G, vonden wij inder-
daad dat er na injectie van anti-GBM antistoffen geen albumi-
nurie ontstond. Dit ondanks het feit dat de glomerulaire 
influx van PMNs en de beschadiging van het glomerulaire 
endotheel geheel gelijk waren aan die in de controlegroep, 
die wel albuminurie ontwikkelde. Beige PMNs toonden in vitro 
een normale productie van het zuurstofmetaboliet superoxide. 
Voorbehandeling van normale ontvangers met middelen die de 
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zuurstofmetabolieten wegvangen, had geen remmende werking op 
de Proteinurie. Deze beide bevindingen maken het waarschijn-
lijk dat zuurstofmetabolieten niet direkt betrokken zijn bij 
de inductie van de albuminurie in het muizemodel. 
Op grond van dit onderzoek komen wij tot de volgende hypothe-
se: Reactieve zuurstofmetabolieten, geproduceerd door geacti-
veerde PMNs, veroorzaken rechtstreeks endotheel-beschadiging 
in de glomerulus. Op de plaatsen waar het endotheel verdwijnt 
kunnen PMNs in direkt contact met de glomerulaire basaalmem-
braan komen. De permeabiliteit van de membraan wordt vervol-
gens verhoogd door de effecten van Proteinasen die ter 
plaatse uit de geactiveerde granulocyten vrijkomen. Het is 
mogelijk dat de werkzaamheid van deze Proteinasen versterkt 
wordt doordat de zuurstofmetabolieten een serie van bescher-
mende antiproteinasen inactiveren, welke onder normale 
omstandigheden een beschermend schild vormen tegen de effec-
ten van Proteinasen. Het model van de beige muis is uitste-
kend geschikt om deze hypothese in vervolgonderzoek te 
testen. 
Het model van de anti-GBM nefritis in de muis kan niet alleen 
meer inzicht verschaffen in de verschillende mechanismen die 
leiden tot immunologische beschadiging, maar is ook bruikbaar 
om het effect van therapeutische ingrepen te onderzoeken. Zo 
hebben wij getracht de vraag te beantwoorden of behandeling 
met cyclosporine A de glomerulaire beschadiging en de albumi-
nurie, die na injectie van anti-GBM antistoffen ontstaan, kan 
remmen. Cyclosporine bleek de albuminurie sterk te verminde-
ren, terwijl de histologische afwijkingen niet beïnvloed 
werden. Via gelijktijdige meting van de glomerulaire filtra-
tiesnelheid konden wij aantonen dat het remmend effect op de 
albuminurie slechts ten dele verklaard kon worden door 
veranderingen in de renale haemodynamiek. Andere factoren, 
zoals een verandering in de permeabiliteit van het glomeru-
laire filter onder invloed van cyclosporine, moeten hierbij 
ook een rol spelen. 
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STELLINGEN 
I 
In de heterologe fase van de anti-GBM nefritis in de muis 
veroorzaken reactieve zuurstofmetabolieten de glomerulaire 
endotheelbeschadiging, terwijl neutrale leukocytaire Proteinasen 
verantwoordelijk zijn voor de verhoogde doorlaatbaarheid van de 
glomerulaire liswand. 
II 
De sterke albuminurie die ontstaat in de heterologe fase van de 
anti-GBM nefritis in de muis is niet afhankelijk van activering 
van het complementsysteem. 
Ill 
Macrofagen spelen geen rol in de heterologe fase van de anti-GBM 
nefritis. 
IV 
De daling van de Proteinurie die ontstaat na toediening van 
cyclosporine wordt niet alleen veroorzaakt door veranderingen 
in de renale haemodynamiek, maar ook door vermindering van de 
permeabiliteit van het glomerulaire filter. 
V 
Bepaling van de relatieve glomerulaire filtratie-snelheid door 
middel van éénpunts-metingen in het bloed vormt bij de muis een 
bruikbaar alternatief voor de klassieke meerpunts-metingen, die 
bij dit kleine proefdier vrijwel onuitvoerbaar zijn. 
VI 
Een onderzoeker met een allergische rhinitis, veroorzaakt door 
muize-allergenen, kan desondanks een drie jaar durend 
wetenschappelijk onderzoek met muizen voltooien, mits hij een 
werkindeling kiest waarbij de dierexperimenten gefaseerd worden 
uitgevoerd. 
VII 
Richtlijnen voor de verzorging van centraal gelegen veneuze 
katheters zijn vaker gebaseerd op geloof en zogenaamde ervaring 
dan op degelijk wetenschappelijk onderzoek. 
VIII 
Behandeling van de anemie van mannelijke haemodialyse-patienten 
met recombinant-humaan erytropoetine leidt vaak tot verbetering 
van de bij terminale nierinsufficientie voorkomende sexuele 
impotentie. 
IX 
Continue arterioveneuze haemofiltratie (CAVH) vormt een aanwinst 
bij de behandeling van patiënten met uitgebreide verbrandingen 
en acute nierinsufficientie. 
X 
Deskundig en zorgvuldig onderzoek van het urinesediment vormt 
een hoeksteen van de nefrologische diagnostiek. 
XI 
Het gebruik van ethyleenoxide voor het steriliseren van 
kunstnieren dient verboden te worden, niet alleen ter voorkoming 
van onnodige milieu-verontreiniging maar ook ter bescherming van 
de patient. 
XII 
De benaming "co-referent", die volgens Nijmeegse universitaire 
traditie gebruikt wordt om in proefschriften een niet-hoogleraar 
promotor of co-promotor aan te duiden, is misleidend en doet geen 
recht aan de omstandigheden waaronder een promotie-onderzoek 
werkelijk wordt uitgevoerd. 
XIII 
Bij ongeoefenden dienen aan het bespelen van de klarinet 
ademhalingsoefeningen en conditietraining vooraf te gaan. 
Nijmegen, 26 september 1989 G. Schrijver 

